{
  "meta": {
    "title": "00021_Late_Night_Pyq_Pyt_Marathon_-_21",
    "url": "https://brainandscalpel.vercel.app/00021-late-night-pyq-pyt-marathon-21-594aef71.html",
    "scrapedAt": "2025-11-29T17:24:34.533Z"
  },
  "questions": [
    {
      "id": 6851,
      "choices": [
        {
          "id": 27372,
          "text": "<p><span style=\"font-size:12.0pt;\">Serotonin</span></p>"
        },
        {
          "id": 27373,
          "text": "<p><span style=\"font-size:12.0pt;\">Histamine</span></p>"
        },
        {
          "id": 27374,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostaglandin</span></p>"
        },
        {
          "id": 27375,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiotensin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following can be responsible for Bezold-Jarisch reflex? (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q4083469",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375886,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Serotonin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bezold-Jarisch reflex is the reflex characterized by bradycardia and hypotension, caused by stimulation of chemoreceptors present in the wall of left ventricles by substances such as alkaloids. It is also called coronary chemoreflex. Vagal fibers form the afferent and efferent pathways of this reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/aiims-physio-nov-2017-02.jpg\" alt=\"\" width=\"800\" height=\"613\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Histamine; C. Prostaglandin and D. Angiotensin:</strong> do not involved in the Bezold-Jarisch reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Serotonin, capsaicin, phenyl biguanide, and veratridine can cause Bezold-Jarisch reflex</strong>.</span></p>",
      "correct_choice_id": 27372,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19960,
      "choices": [
        {
          "id": 79801,
          "text": "<p><span style=\"font-size:12.0pt;\">No change</span></p>"
        },
        {
          "id": 79802,
          "text": "<p><span style=\"font-size:12.0pt;\">Becomes more negative</span></p>"
        },
        {
          "id": 79803,
          "text": "<p><span style=\"font-size:12.0pt;\">Becomes more positive</span></p>"
        },
        {
          "id": 79804,
          "text": "<p><span style=\"font-size:12.0pt;\">First becomes more positive, then negative</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was brought to the hospital after a road traffic accident. He had severe muscle injury and his serum K+ level was found to be 5.5 mEq/L. What change will happen to the resting membrane potential in this patient? (</span>NEET PG 2023)</p>",
      "unique_key": "Q4834506",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375887,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Becomes more positive</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the given clinical scenario, the patient has hyperkalemia. Hyperkalemia can cause a shift in the resting membrane potential towards a more positive value, increased cell excitability, and impairments in membrane potential changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hyperkalemia can affect the resting membrane potential of cells, including neurons and muscle cells, in the following ways:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Increased Resting Membrane Potential: Normally, the resting membrane potential is around -70 millivolts (mV) in neurons. However, in hyperkalemia, the elevated extracellular potassium concentration can lead to an increased positive charge outside the cell. This positive charge tends to depolarize the cell membrane, shifting the resting membrane potential towards a more positive value.</span></li><li><span style=\"font-size:12.0pt;\">Altered Excitability: The increased resting membrane potential caused by hyperkalemia can make the cell more excitable. It reduces the threshold required for an action potential to be initiated, making the cell more likely to depolarize and generate an action potential even in response to weaker stimuli.</span></li><li><span style=\"font-size:12.0pt;\">Impaired Membrane Potential Changes: Hyperkalemia can interfere with the ability of the cell membrane to depolarize and repolarize properly during an action potential. It reduces the electrochemical gradient for sodium (Na+) entry during depolarization and decreases the driving force for potassium (K+) exit during repolarization. This can result in slower and less efficient propagation of action potentials.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;Disrupted Ionic Balance: Elevated potassium levels can disrupt the balance of other ions, such as sodium and calcium, which are essential for normal cell function. The altered ionic balance can interfere with the proper functioning of ion channels and other membrane proteins involved in generating and regulating action potentials.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. No change:</strong> Incorrect. Changes in extracellular potassium concentrations directly impact the resting membrane potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Becomes more negative:</strong> Incorrect. An increase in extracellular potassium concentration results in depolarization (more positive resting membrane potential), not hyperpolarization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. First becomes more positive, then negative:</strong> Incorrect. While complex fluctuations can occur under dynamic conditions, primarily, hyperkalemia causes a persistent depolarization (more positive shift) without an initial opposite change.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In hyperkalemia, as seen in patients with severe muscle injury, the resting membrane potential becomes more positive due to decreased potassium efflux, leading to increased excitability of nerve and muscle cells. This can affect the normal function of these cells, potentially leading to complications such as muscle weakness or cardiac arrhythmias.</span></p>",
      "correct_choice_id": 79803,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54790,
      "choices": [
        {
          "id": 218625,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase in glomerular capillary hydrostatic pressure</span></span></span></p>"
        },
        {
          "id": 218626,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decrease in glomerular capillary oncotic pressure</span></span></span></p>"
        },
        {
          "id": 218627,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase in renal plasma flow</span></span></span></p>"
        },
        {
          "id": 218628,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase in Bowman&#39;s capsule hydrostatic pressure</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following decreases GFR? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q8202028",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375888,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Increase in Bowman&#39;s capsule hydrostatic pressure</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glomerular Filtration Rate (GFR) is determined by the balance of pressures acting on the glomerulus. The key pressures involved are the glomerular capillary hydrostatic pressure, which drives filtration, and the oncotic pressure, which opposes it. Additionally, the hydrostatic pressure within Bowman&#39;s capsule also opposes filtration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Increase in Bowman&#39;s capsule hydrostatic pressure</span></strong><span style=\"font-size:12.0pt\">: This is the back pressure exerted by the fluid already in Bowman&#39;s capsule. If this pressure increases, it opposes the hydrostatic pressure of the glomerular capillaries, leading to a decrease in GFR. For example, conditions such as ureteric obstruction can increase this pressure, resulting in reduced GFR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Increase in glomerular capillary hydrostatic pressure</span></strong><span style=\"font-size:12.0pt\">: This pressure pushes fluid out of the capillaries and into Bowman&#39;s capsule, thus increasing GFR. Therefore, increasing this pressure would not decrease GFR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Decrease in glomerular capillary oncotic pressure</span></strong><span style=\"font-size:12.0pt\">: Oncotic pressure is the &quot;holding&quot; pressure due to plasma proteins. A decrease in this pressure would result in less opposition to filtration, thereby increasing GFR, not decreasing it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Increase in renal plasma flow</span></strong><span style=\"font-size:12.0pt\">: An increase in renal plasma flow generally leads to an increase in GFR because more plasma is being filtered through the kidneys.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An increase in Bowman&#39;s capsule hydrostatic pressure decreases GFR</span></span></span></p>",
      "correct_choice_id": 218628,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6729,
      "choices": [
        {
          "id": 26885,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Zonula occludens</span></span></span></p>"
        },
        {
          "id": 26886,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Fascia adherens</span></span></span></p>"
        },
        {
          "id": 26887,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gap junctions</span></span></span></p>"
        },
        {
          "id": 26888,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Macula adherens</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cellular junctions present in a cardiac muscle are all except? (</span></span>AIIMS May 2017)</p>",
      "unique_key": "Q8099899",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375889,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Zonula occludens</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zonula occludens is the other name for the tight junction. It is absent in a cardiac muscle.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cardiac muscle fibers are striated bound by sarcolemma with a centrally placed nucleus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myofibrils are embedded in the sarcoplasm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sarcomere of the cardiac muscle has all the contractile proteins, namely actin, myosin, troponin and tropomyosin. Cardiac muscle fiber is branched.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intercalated disk - formed by the fusion of the membrane of the cardiac muscle branches.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-175907.png\" style=\"height:335px; width:400px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Fascia adherens</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - broad intercellular junction both of sarcolemma and intercalated disc of cardiac muscle fibers that anchors actin filaments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Gap junction - </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">fused membranes adjacent muscle fibers form gap junctions. It is permeable to ions and it facilitates the rapid conduction of action potential from one fiber to another.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Macula adherens</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Also called as desmosomes are intercellular junctions specialized for strong adhesion. They prevent the separation of cardiac myocytes during individual fiber contraction by binding to intracellular intermediate filaments (cytoskeleton), which joins cells together.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Zonula occludens are absent in cardiac muscle; instead, this muscle type prominently features fascia adherens, gap junctions, and macula adherens, which are essential for mechanical stability and coordinated contraction.</span></span></span></span></p>",
      "correct_choice_id": 26885,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13828,
      "choices": [
        {
          "id": 55273,
          "text": "<p>1</p>"
        },
        {
          "id": 55274,
          "text": "<p>2</p>"
        },
        {
          "id": 55275,
          "text": "<p>3</p>"
        },
        {
          "id": 55276,
          "text": "<p>4</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with a unilateral throbbing headache, photophobia, and excessive lacrimation. He also complains of hemifacial pain on clenching of teeth. On examination, pupillary reflex, light reflex, and accommodation reflex are normal. Which of the following marked nerves is involved in the above scenario?&nbsp;</span><span style=\"font-size:11pt;\">(NEET PG 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-861.jpg\" alt=\"\" width=\"300\" height=\"323\"></span></p>",
      "unique_key": "Q8881728",
      "question_audio": null,
      "question_video": null,
      "map_id": 12375930,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The above patient presents with features suggesting an involvement of the trigeminal nerve. The structure marked 3 is the <strong>trigeminal nerve</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The various clinical features associated with trigeminal nerve injury are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Facial pain:&nbsp;</strong>Trigeminal neuralgia is a condition characterized by severe facial pain, often described as sharp, stabbing, or electric shock-like sensations. The pain is typically triggered by routine activities such as eating, talking, or touching specific areas of the face.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Sensory abnormalities:&nbsp;</strong>The trigeminal nerve carries sensory information from the face, including touch, temperature, and pain. When affected, sensory abnormalities may manifest as numbness, tingling, or altered sensation in the face. The distribution of these sensory disturbances depends on which branches of the trigeminal nerve are involved.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Facial muscle weakness:&nbsp;</strong>The trigeminal nerve also supplies motor fibers to the muscles involved in chewing, such as the <strong>muscles of mastication</strong>. In certain conditions, such as trigeminal neuropathy or facial nerve palsy involving the trigeminal nerve, weakness or paralysis of these muscles can occur, leading to difficulty in chewing and controlling facial expressions.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Corneal reflex abnormalities:&nbsp;</strong>The ophthalmic branch of the trigeminal nerve is responsible for the corneal reflex, which involves blinking in response to corneal stimulation. Disorders affecting the trigeminal nerve may result in a diminished or absent corneal reflex on the affected side.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Headache:&nbsp;</strong>Some disorders involving the trigeminal nerve, such as trigeminal autonomic cephalalgias (e.g., cluster headaches), can cause severe headaches on one side of the head. These headaches often occur in close proximity to the trigeminal nerve distribution.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-862.jpg\" alt=\"\" width=\"700\" height=\"511\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other marked structures:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">1- Optic nerve</span></li><li><span style=\"font-size:12.0pt;\">2- Abducent nerve</span></li><li><span style=\"font-size:12.0pt;\">4- Vestibulo cochlear nerve</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Optic Nerve (II)</strong>: The optic nerve is responsible for transmitting visual information from the retina to the brain. It is purely sensory in function. It begins at the retina, passes through the optic canal of the sphenoid bone, and joins the optic nerve of the opposite side at the optic chiasm. At this junction, fibers from the nasal half of each retina cross over.&nbsp; Damage to the optic nerve can result in vision loss. Glaucoma, a condition with increased intraocular pressure, can damage the optic nerve and lead to blindness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Abducent Nerve (VI)</strong>: This nerve is a motor nerve that innervates the lateral rectus muscle, which abducts the eye (moves it laterally). It originates in the pons of the brainstem and travels through the superior orbital fissure to reach the orbit. Damage to this nerve can result in an inability to abduct the affected eye, leading to a condition called lateral rectus palsy. This can manifest as double vision (diplopia) when looking to the side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vestibulocochlear Nerve (VIII)</strong>: It has two parts: the cochlear nerve (for hearing) and the vestibular nerve (for balance). It originates in the inner ear and enters the brainstem at the cerebellopontine angle. Damage can lead to issues like sensorineural hearing loss or balance disorders like vertigo.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Trigeminal Nerve (V)</strong> is the largest cranial nerve and has both sensory and motor functions. Sensory functions include facial sensation, and the motor function is mainly for muscles of mastication (chewing).&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It has three main branches: ophthalmic (V1), maxillary (V2), and mandibular (V3).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The nerve originates in the pons and exits the brainstem to innervate its various targets.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Trigeminal neuralgia is a condition where there's intense, stabbing pain along the path of the nerve. It's considered one of the most painful conditions in medicine.</span></p>",
      "correct_choice_id": 55275,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57186,
      "choices": [
        {
          "id": 228133,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">60 minutes </span></span></span></p>"
        },
        {
          "id": 228134,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">90 minutes </span></span></span></p>"
        },
        {
          "id": 228135,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">120 minutes </span></span></span></p>"
        },
        {
          "id": 228136,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">150 minutes</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At what intervals do migratory motor complexes (MMCs) reoccur in the gastrointestinal tract? (AIIMS NOV 2016)</span></span></p>",
      "unique_key": "Q2018452",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378824,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Answer: B. 90 minutes</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Migratory motor complexes are cyclical, recurring motor activities that occur during the fasting state to facilitate the clearance of undigested particles and secretions from the stomach through to the small intestine. They appear every 90 minutes. These complexes are driven by motilin, a hormone whose levels peak periodically, promoting these rhythmic contractions that sweep through the gut. This mechanism prevents bacterial overgrowth and ensures that the digestive tract is ready for the next meal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option a (60 minutes) is incorrect as it does not align with the typical 90-minute cycle of MMCs.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option c (120 minutes) and option d (150 minutes) are incorrect as they exceed the normal frequency of MMCs, which generally occur every 90 minutes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">&nbsp;Migratory motor complexes reappear every 90 minutes in the gut, primarily driven by peaks in motilin levels during the fasting state, facilitating the clearance of the gastrointestinal tract.</span></span></span></p>",
      "correct_choice_id": 228134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6839,
      "choices": [
        {
          "id": 27324,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Burst forming units</span></span></span></p>"
        },
        {
          "id": 27325,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colony forming units</span></span></span></p>"
        },
        {
          "id": 27326,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Late erythroblast stage</span></span></span></p>"
        },
        {
          "id": 27327,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normoblast stage</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The earliest stage at which erythropoietin is effective in red blood cell formation? (</span></span></span>AIIMS May 2018)</p>",
      "unique_key": "Q1513089",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378875,
      "difficulty_level": "difficult",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Burst forming units</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythropoietin (EPO) primarily acts on early erythroid progenitor cells, particularly the Burst Forming Unit-Erythroid (BFU-E). The BFU-E is among the earliest erythroid progenitor cells and requires EPO to proliferate and differentiate into more mature forms of red blood cell precursors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mechanism of Action:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BFU-E:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Burst Forming Unit-Erythroid is sensitive to erythropoietin and under its influence can proliferate and differentiate, giving rise to Colony Forming Unit-Erythroid (CFU-E).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CFU-E:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This stage follows BFU-E and leads to the development of more differentiated erythroid cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of EPO:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EPO binds to specific receptors on the surface of erythroid progenitor cells, initiating a cascade of intracellular events that promote cell survival, proliferation, and differentiation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Colony forming units:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a later stage than BFU-E and is also influenced by EPO but not the earliest.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Late erythroblast stage:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EPO&#39;s influence diminishes as cells mature to this stage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Normoblast stage:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a more mature stage of erythroid development where EPO has minimal effect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythropoietin is most effective at the burst forming unit stage of red blood cell development, where it stimulates the proliferation and differentiation of these early progenitor cells into more mature red blood cells.</span></span></p>",
      "correct_choice_id": 27324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34050,
      "choices": [
        {
          "id": 136035,
          "text": "<p><span style=\"font-size:12.0pt;\">Located in the thick muscle layer</span></p>"
        },
        {
          "id": 136036,
          "text": "<p><span style=\"font-size:12.0pt;\">Stretch receptors</span></p>"
        },
        {
          "id": 136037,
          "text": "<p><span style=\"font-size:12.0pt;\">Afferent fibers pass via the glossopharyngeal nerve branch</span></p>"
        },
        {
          "id": 136038,
          "text": "<p><span style=\"font-size:12.0pt;\">Sensitive to changes in arterial pressure</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is incorrect about baroreceptors?&nbsp;</span>(INICET NOVEMBER 2023)</p>",
      "unique_key": "Q3856721",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378876,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Located in the thick muscle layer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Baroreceptors are located in the&nbsp;adventitial layer of the carotid bulb of the internal carotid artery (not in the thick muscle layer); where the walls are typically thinner to allow for the detection of pressure changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Stretch receptors:</strong> Baroreceptors are indeed stretch receptors; they respond to the stretching of the arterial wall as blood pressure changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Afferent fibers pass via the glossopharyngeal nerve branch:</strong> Afferent fibers from the carotid sinus baroreceptors pass through the glossopharyngeal nerve (cranial nerve IX) to the brainstem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Sensitive to changes in arterial pressure:</strong> Baroreceptors are sensitive to changes in arterial pressure; they quickly respond to fluctuations in blood pressure by sending signals to the central nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Baroreceptors are located in the adventitial layer, not in the thick muscle layer, and they are sensitive to changes in arterial pressure, functioning as stretch receptors with afferent fibers passing via the glossopharyngeal nerve.`1</span></p>",
      "correct_choice_id": 136035,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6744,
      "choices": [
        {
          "id": 26945,
          "text": "<p><span style=\"font-size:12.0pt;\">Amphipathic</span></p>"
        },
        {
          "id": 26946,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrophobic</span></p>"
        },
        {
          "id": 26947,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrophilic</span></p>"
        },
        {
          "id": 26948,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following types of amino acids are present in the trans-membranous part of the membrane receptor? (</span>INICET May 2020)</p>",
      "unique_key": "Q1936606",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378877,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hydrophobic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Integral or transmembrane proteins are the proteins that pass through entire thickness of cell membrane from one side to the other side. These proteins are tightly bound with the cell membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The trans membranous part of the membrane receptor consists of hydrophobic amino acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The central core of the cell membrane is hydrophobic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/29/screenshot-2024-05-29-115348.png\" alt=\"\" width=\"600\" height=\"475\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Amphipathic:</strong> Incorrect. Amphipathic molecules contain both hydrophobic and hydrophilic regions, but the transmembrane segments of proteins are primarily hydrophobic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hydrophilic:</strong> Incorrect. Hydrophilic amino acids have polar side chains that would not favorably interact with the hydrophobic core of the lipid bilayer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. None of the above:</strong> Incorrect. Hydrophobic amino acids are indeed present in the transmembranous part of the membrane receptor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The transmembrane regions of membrane receptors are composed of hydrophobic amino acids, allowing them to stably integrate into the hydrophobic core of the lipid bilayer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Examples of integral protein:</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-roman;\"><li><span style=\"font-size:12.0pt;\">Cell adhesion proteins</span></li><li><span style=\"font-size:12.0pt;\">Cell junction proteins</span></li><li><span style=\"font-size:12.0pt;\">Some carrier (transport) proteins</span></li><li><span style=\"font-size:12.0pt;\">Channel proteins</span></li><li><span style=\"font-size:12.0pt;\">Some hormone receptors</span></li><li><span style=\"font-size:12.0pt;\">Antigens</span></li><li><span style=\"font-size:12.0pt;\">Some enzymes.</span></li></ol>",
      "correct_choice_id": 26946,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8783,
      "choices": [
        {
          "id": 35099,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leydig cells</span></span></span></p>"
        },
        {
          "id": 35100,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sertoli cells</span></span></span></p>"
        },
        {
          "id": 35101,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Seminiferous tubules</span></span></span></p>"
        },
        {
          "id": 35102,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Epididymis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Testosterone production is mainly contributed by?(NEET PG 2019) </span></span></span></p>",
      "unique_key": "Q1908597",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378878,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Leydig cell</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Testosterone production is mainly contributed by Leydig cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In puberty, the hypothalamic-pituitary-gonadal axis&nbsp;plays&nbsp;a major role in regulating testosterone levels and gonadal function. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The hypothalamus secretes GnRH, which travels down the&nbsp;hypothalamohypophyseal&nbsp;portal system to the anterior pituitary, which secretes luteinizing hormone (LH) and follicle-stimulating&nbsp;hormone (FSH). </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LH and FSH are two gonadotropic hormones that travel through the blood and act on receptors in the gonads. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LH, in particular, acts on the Leydig cells to increase testosterone production. Testosterone limits its own secretion via negative feedback.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sertoli cells</span></strong><span style=\"font-size:12.0pt\">: Incorrect as Sertoli cells are primarily involved in the nourishment and support of developing spermatozoa, not in the production of testosterone.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Seminiferous tubules</span></strong><span style=\"font-size:12.0pt\">: Incorrect because while these structures within the testes are involved in sperm production, the cells directly responsible for testosterone production are the Leydig cells, not the tubules themselves.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Epididymis</span></strong><span style=\"font-size:12.0pt\">: Incorrect as the epididymis is involved in the storage, maturation, and transport of sperm cells, not hormone production.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Testosterone production is mainly contributed by Leydig cells in the testes, which are specifically stimulated by luteinizing hormone (LH) from the anterior pituitary gland. This hormonal production is crucial for male reproductive and general health.</span></span></span></p>",
      "correct_choice_id": 35099,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6775,
      "choices": [
        {
          "id": 27069,
          "text": "<p><span style=\"font-size:12.0pt;\">Junction of thick descending limb and DCT</span></p>"
        },
        {
          "id": 27070,
          "text": "<p><span style=\"font-size:12.0pt;\">Junction of thick descending limb and PCT</span></p>"
        },
        {
          "id": 27071,
          "text": "<p><span style=\"font-size:12.0pt;\">Junction of thick ascending limb and DCT</span></p>"
        },
        {
          "id": 27072,
          "text": "<p><span style=\"font-size:12.0pt;\">Junction of DCT and collecting duct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Macula densa is made of specialized cells located at: (INICET MAY 2022)</span></p>",
      "unique_key": "Q7249737",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378879,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Junction of thick ascending limb and DCT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Macula densa are specialized cells in the end portion of thick ascending segment before it opens into distal convoluted tubule. It is situated between afferent and efferent arterioles of the same nephron. It is very close to afferent arteriole. Macula densa is formed by tightly packed cuboidal epithelial cells. It forms the part of the juxtaglomerular apparatus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-115726.png\" alt=\"\" width=\"800\" height=\"426\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Junction of thick descending limb and DCT:&nbsp;</strong>Incorrect. The macula densa is not located at the junction of the thick descending limb and the distal convoluted tubule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Junction of thick descending limb and PCT:&nbsp;</strong>Incorrect. The macula densa is not found at the junction of the thick descending limb and the proximal convoluted tubule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Junction of DCT and collecting duct:&nbsp;</strong>Incorrect. The macula densa is located before the DCT opens into the collecting duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The macula densa is composed of specialized cells located at the junction of the thick ascending limb and the distal convoluted tubule (DCT), playing a crucial role in the juxtaglomerular apparatus.</span></p>",
      "correct_choice_id": 27071,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6871,
      "choices": [
        {
          "id": 27452,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased renal blood flow</span></p>"
        },
        {
          "id": 27453,
          "text": "<p><span style=\"font-size:12.0pt;\">Efferent arteriolar constriction</span></p>"
        },
        {
          "id": 27454,
          "text": "<p><span style=\"font-size:12.0pt;\">Ureteric stone</span></p>"
        },
        {
          "id": 27455,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased oncotic pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">GFR is increased by all except? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q6257768",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378880,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ureteric stone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ureteric stone causes a reduction in glomerular filtration rate (GFR).</span></p><p><span style=\"font-size:12.0pt;\">Ureteral obstruction decreases glomerular filtration rate (GR) due to a reduction in a single-nephron glomerular filtration rate (SNGFR) and a reduced number of filtering nephrons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increased renal blood flow:</strong> Correct. Increased renal blood flow increases GFR by increasing glomerular capillary hydrostatic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Efferent arteriolar constriction:</strong> Correct. Efferent arteriolar constriction increases GFR by increasing glomerular capillary hydrostatic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Decreased oncotic pressure:</strong> Correct. Decreased oncotic pressure in the glomerular capillaries increases GFR by reducing the opposing colloid osmotic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-174822.jpg\" alt=\"\" width=\"1000\" height=\"830\"></strong></span></p>",
      "correct_choice_id": 27454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6958,
      "choices": [
        {
          "id": 27800,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2 are correct</span></p>"
        },
        {
          "id": 27801,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, and 4 are correct</span></p>"
        },
        {
          "id": 27802,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, and 5 are correct</span></p>"
        },
        {
          "id": 27803,
          "text": "<p><span style=\"font-size:12.0pt;\">1. 2. and 5 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Substances and the type of transport across a membrane are given below, choose the correct combination: (</span>INICET Nov 2022)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Oxygen: Simple diffusion</span></li><li><span style=\"font-size:12.0pt;\">Glucose: Facilitated diffusion</span></li><li><span style=\"font-size:12.0pt;\">Sodium: Voltage-gated channel</span></li><li><span style=\"font-size:12.0pt;\">Sodium: Secondary active transport</span></li><li><span style=\"font-size:12.0pt;\">Calcium: Active transport</span></li></ol>",
      "unique_key": "Q5968523",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378881,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 2, 3, 4, and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>All the given combinations are correct for the types of transport across a membrane:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Oxygen. Simple diffusion: </strong>Oxygen is a non-polar molecule and diffuses directly across the lipid bilayer of cell membranes by simple diffusion. This process does not require any membrane proteins or energy input.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Glucose. Facilitated diffusion: </strong>Glucose is transported into cells via facilitated diffusion, which involves specific carrier proteins (such as GLUT transporters). This process allows glucose to move down its concentration gradient without the use of energy.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Sodium. Voltage-gated channel: </strong>Voltage-gated sodium channels are integral membrane proteins that open and close in response to changes in membrane potential. These channels allow the selective passage of sodium ions during the action potentials in neurons and muscle cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Sodium. Secondary active transport: </strong>Sodium ions are also involved in secondary active transport, where the movement of sodium down its electrochemical gradient (established by primary active transport) drives the transport of another substance against its gradient. An example is the sodium-glucose cotransporter (SGLT).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. Calcium. Active transport: </strong>Calcium ions are actively transported across cell membranes using ATP-driven pumps such as the Ca-ATPase (also known as the calcium pump). This process maintains low intracellular calcium levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All of the mentioned substances and their associated transport mechanisms are correct: Oxygen via simple diffusion, glucose via facilitated diffusion, sodium via voltage-gated channels and secondary active transport, and calcium via active transport.</span></p>",
      "correct_choice_id": 27802,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57187,
      "choices": [
        {
          "id": 228137,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Hyperosmolar Hyperglycemic State (HHS)</span></span></span></p>"
        },
        {
          "id": 228138,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Nephrogenic Diabetes Insipidus</span></span></span></p>"
        },
        {
          "id": 228139,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Central (Pituitary) Diabetes Insipidus</span></span></span></p>"
        },
        {
          "id": 228140,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 45-year-old woman presents with complaints of frequent urination, nocturia, and recent episodes of bedwetting. She reports drinking large amounts of water due to constant thirst. A 24-hour urine collection reveals a total volume of 7 liters with an osmolarity of 260 mOsm/L. Blood tests show serum sodium at 148 mEq/L. ADH assay reveals a level of 0.8 pg/mL, and MRI of the brain reveals the absence of the normal bright spot on T1-weighted images. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q2003600",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378882,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Central (Pituitary) Diabetes Insipidus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The patient&#39;s clinical presentation, including excessive urination, nocturia, and low urine osmolarity, along with a low ADH level and absence of the posterior pituitary bright spot on MRI, strongly indicate Central Diabetes Insipidus (CDI). In CDI, the deficiency of antidiuretic hormone (ADH) production or release from the posterior pituitary leads to inadequate water reabsorption in the kidneys, resulting in high urine output and low osmolarity. The low ADH levels and MRI findings confirm the diagnosis, distinguishing it from other forms of polyuria such as nephrogenic DI, where ADH is produced but not effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Hyperosmolar Hyperglycemic State (HHS)</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">HHS typically occurs in patients with poorly controlled diabetes and presents with severe hyperglycemia, dehydration, and altered mental status. Although it can cause polyuria, it would not result in low ADH levels or the absence of the posterior pituitary bright spot on MRI, making this diagnosis less likely in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Nephrogenic Diabetes Insipidus</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Nephrogenic DI results from kidney resistance to ADH, not from a deficiency in ADH production. ADH levels would be elevated or normal, and there would be no absence of the posterior pituitary bright spot on MRI, which helps differentiate it from central DI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">SIADH is characterized by excessive ADH secretion, leading to water retention, low serum sodium, and concentrated urine. It would present with low urine output, high urine osmolarity, and hyponatremia, which is the opposite of this patient&rsquo;s presentation, making SIADH an incorrect diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Central Diabetes Insipidus (CDI) is caused by a deficiency in ADH production or release, leading to high urine output, low urine osmolarity, and normal to low ADH levels. Diagnostic confirmation includes water deprivation tests, desmopressin response, and MRI findings such as absence of the posterior pituitary bright spot, differentiating it from nephrogenic DI and conditions like HHS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">MMS algorithm for finding out the cause</span></u></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/14/picture1_g9h6Z7f.jpg\" style=\"height:298px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 228139,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6514,
      "choices": [
        {
          "id": 26025,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium chloride</span></p>"
        },
        {
          "id": 26026,
          "text": "<p><span style=\"font-size:12.0pt;\">Clarithromycin</span></p>"
        },
        {
          "id": 26027,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 26028,
          "text": "<p><span style=\"font-size:12.0pt;\">Triamterene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male patient was diagnosed with atrial fibrillation with a controlled ventricular rate. The medication charts reveal that he was taking digoxin, potassium chloride, clarithromycin, atenolol, and triamterene. Suspecting the symptoms to be due to digoxin overdose, plasma levels of digoxin were ordered. It was found that his blood levels of digoxin have increased significantly. Which of his medications is most likely responsible for this increase in digoxin levels? (NEET PG 2021)</span></p>",
      "unique_key": "Q1153669",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378973,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Clarithromycin.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Clarithromycin is known to inhibit the cytochrome P450 system, which is involved in the metabolism of many drugs, including digoxin. By inhibiting the metabolism of digoxin, clarithromycin can lead to elevated levels of digoxin in the blood, increasing the risk for digoxin toxicity.</span></li><li><span style=\"font-size:12.0pt;\">Clarithromycin also acts as an inhibitor of the P-glycoprotein and can precipitate Digoxin toxicity. P glycoproteins are drug efflux pumps in the intestine that lead to a decrease in the bioavailability of drugs. Digoxin is one of the drugs that utilizes this mechanism for its metabolism. Therefore, the drugs which inhibit the Pgp can lead to the increased plasma concentration of Digoxin and lead to its toxicity.</span></li><li><span style=\"font-size:12.0pt;\">Other drugs that inhibit the Pgp include&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Amiodarone</span></li><li><span style=\"font-size:12.0pt;\">Verapamil</span></li><li><span style=\"font-size:12.0pt;\">Diltiazem</span></li><li><span style=\"font-size:12.0pt;\">Itraconazole</span></li><li><span style=\"font-size:12.0pt;\">Propafenone</span></li><li><span style=\"font-size:12.0pt;\">Flecainide&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Quinidine.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Potassium chloride:</strong> This medication primarily affects potassium levels and has no significant interaction with digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Atenolol</strong>: Atenolol, a beta-blocker, is not known to significantly interact with digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Triamterene</strong>: This diuretic medication primarily affects sodium and potassium levels and is not known to have a significant impact on digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clarithromycin can significantly increase plasma levels of digoxin by inhibiting its metabolism through the cytochrome P450 system and by inhibiting P-glycoprotein, leading to an increased risk of digoxin toxicity.</span></p>",
      "correct_choice_id": 26026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6736,
      "choices": [
        {
          "id": 26913,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dead space volume</span></span></span></p>"
        },
        {
          "id": 26914,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FRC</span></span></span></p>"
        },
        {
          "id": 26915,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tidal volume</span></span></span></p>"
        },
        {
          "id": 26916,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diffusion capacity</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single breath nitrogen method is used for measuring? (</span></span>AIIMS May 2019)</p>",
      "unique_key": "Q9739320",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378974,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Dead space volume</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Air in the respiratory passages where gas exchange does not occur, such as the nose, pharynx, and trachea are called dead space.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anatomical dead space can be measured by the single-breath N2 curve (<strong>Fowler&#39;s method</strong>).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In making this measurement, the subject suddenly takes a deep breath of oxygen.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This fills the entire dead space with pure oxygen. Some oxygen also mixes with the alveolar air but does not completely replace this air. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Then the person expires through a rapidly recording nitrogen meter, which makes the record</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Record of the changes in nitrogen concentration in the expired air after a single previous inspiration of pure oxygen. This record can be used to calculate dead space.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. FRC (Functional Residual Capacity):&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. FRC is usually measured using techniques such as body plethysmography or helium dilution, not the single breath nitrogen method.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Tidal volume: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Tidal volume is the amount of air inhaled or exhaled during a normal breath and is measured directly using spirometry.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Diffusion capacity:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Diffusion capacity, often measured by the DLCO (Diffusing Capacity of the Lungs for Carbon Monoxide) test, assesses the ability of gases to diffuse across the alveolar-capillary membrane, not by the single breath nitrogen method.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The single breath nitrogen method (Fowler&#39;s method) is used to measure the anatomical dead space volume, which is the volume of air in the respiratory passages where no gas exchange occurs. This method provides a precise measurement of dead space by analyzing the nitrogen concentration in expired air following a single breath of pure oxygen.</span></span></span></p>",
      "correct_choice_id": 26913,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6933,
      "choices": [
        {
          "id": 27700,
          "text": "<p><span style=\"font-size:12.0pt;\">Alveolar duct</span></p>"
        },
        {
          "id": 27701,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchi</span></p>"
        },
        {
          "id": 27702,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory bronchioles</span></p>"
        },
        {
          "id": 27703,
          "text": "<p><span style=\"font-size:12.0pt;\">Small bronchioles</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following has the highest airway resistance? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q5556750",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378975,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Bronchi</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Among the given options, bronchi (medium-sized airway) offer maximum resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best answer here is bronchi, as the other options suggest smaller airways and bronchi is the only medium-sized airway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Since the airway branches in each generation exist in parallel rather than in series, smallest airway contributes little to overall resistance. As the parallel branching increases, the resistance decreases because the total cross-sectional diameter of small airways put together is high resulting in less resistance. Also, airflow velocity decreases substantially because the effective cross-sectional area increases (i.e., the flow becomes laminar).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other factors affecting airway resistance:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Lung volume, as lung volume increases the resistance decreases and vice versa. Lung volume increases the trans airway pressure thus increasing the caliber of the airway.</span></li><li><span style=\"font-size:12.0pt;\">Airway mucus, edema, and contraction of bronchial smooth muscle increase the airway resistance. Its clinical application is seen in asthma, bronchitis, and emphysema</span></li><li><span style=\"font-size:12.0pt;\">The density and viscosity of inspired gas also contribute to airway resistance. A gas with more density imparts more resistance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Alveolar duct and C. Respiratory bronchioles</strong>: These smaller airways have much lower resistance due to their large total cross-sectional area, which reduces resistance despite their small individual diameters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Small bronchioles</strong>: Similar to the respiratory bronchioles, their high number and extensive branching reduce overall resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bronchi, the medium-sized airways, have the highest airway resistance due to their relatively narrow diameter compared to the total cross-sectional area of smaller airways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Airflow can be derived from Poiseuille- Hagen formula:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-nov-1-9.jpg\" alt=\"\" width=\"500\" height=\"129\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Where:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">R is the resistance</span></li><li><span style=\"font-size:12.0pt;\">is pie symbol</span></li><li><span style=\"font-size:12.0pt;\">r is radius</span></li><li><span style=\"font-size:12.0pt;\">is viscosity</span></li><li><span style=\"font-size:12.0pt;\">L is length</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to Poisuilles formula, Airway resistance is inversely proportional to the fourth power radius.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Poiseuille- Hagen formula suggests that the smallest airways are the major site of resistance.</span></p>",
      "correct_choice_id": 27701,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6883,
      "choices": [
        {
          "id": 27500,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral</span></p>"
        },
        {
          "id": 27501,
          "text": "<p><span style=\"font-size:12.0pt;\">Rectal</span></p>"
        },
        {
          "id": 27502,
          "text": "<p><span style=\"font-size:12.0pt;\">Infrared tympanic thermometer</span></p>"
        },
        {
          "id": 27503,
          "text": "<p><span style=\"font-size:12.0pt;\">Axillary</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A soldier posted in Siachen is brought to you in the ER. In order to rule out hypothermia, how do you best measure his temperature? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q4266897",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378976,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Rectal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the given clinical scenario measuring rectal temperature would be preferred over other methods in a case of suspected hypothermia, especially in a soldier posted in Siachen where the ambient temperature can be extremely low. Rectal temperature is considered the most accurate method for measuring core body temperature because it reflects the temperature of the body's core organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A. Oral:</strong> Incorrect. Oral temperature measurements can be influenced by ambient temperature and recent oral intake, making them less reliable in extreme conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Infrared tympanic thermometer:</strong> Incorrect. While it measures the temperature of the eardrum, which can represent core body temperature, it may not be reliable if not inserted adequately or if there is earwax obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Axillary:</strong> Incorrect. Axillary temperature measurements are less accurate and can be significantly influenced by environmental factors, making them unreliable in cold environments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For accurate measurement of core body temperature in cases of suspected hypothermia, rectal temperature is the preferred method, especially in extreme environmental conditions like those in Siachen.</span></p>",
      "correct_choice_id": 27501,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6908,
      "choices": [
        {
          "id": 27600,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
        },
        {
          "id": 27601,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        },
        {
          "id": 27602,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Glucagon</span></p>"
        },
        {
          "id": 27603,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Parathormone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these hormones have intracellular receptors? (</span>INICET Nov 2020)</p>",
      "unique_key": "Q6905634",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378977,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Thyroxine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Thyroxine hormone act by binding to intracellular nuclear receptors.</span></li><li><span style=\"font-size:12.0pt;\">All other hormones mentioned in the options bind to receptors on the cell membrane.</span></li><li><span style=\"font-size:12.0pt;\">Thyroxine crosses the plasma membrane for its action.</span></li><li><span style=\"font-size:12.0pt;\">The thyroid hormone receptors are either attached to the DNA genetic strands or located in proximity to them. The thyroid hormone receptor usually forms a heterodimer with retinoid X receptor (RXR) at specific thyroid hormone response elements on the DNA. On binding with thyroid hormone, the receptors become activated and initiate the transcription process.</span></li><li><span style=\"font-size:12.0pt;\">Then large numbers of different types of messenger RNA are formed, followed within another few minutes or hours by RNA translation on the cytoplasmic ribosomes to form hundreds of new intracellular proteins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Epinephrine</strong>: Epinephrine binds to adrenergic receptors on the cell membrane, which are G protein-coupled receptors, and does not use intracellular receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Glucagon</strong>: Glucagon binds to glucagon receptors on the cell membrane, which are also G protein-coupled receptors, and does not use intracellular receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Parathormone</strong>: Parathormone (PTH) binds to PTH receptors on the cell membrane, which are G protein-coupled receptors, and does not use intracellular receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thyroxine acts by binding to intracellular nuclear receptors, initiating transcription and subsequent protein synthesis. This distinguishes it from hormones like epinephrine, glucagon, and parathormone, which bind to receptors on the cell membrane.</span></p>",
      "correct_choice_id": 27600,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8805,
      "choices": [
        {
          "id": 35187,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factor 2</span></span></span></p>"
        },
        {
          "id": 35188,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factor 11</span></span></span></p>"
        },
        {
          "id": 35189,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tissue factor</span></span></span></p>"
        },
        {
          "id": 35190,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factor 5</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following clotting factors would have decreased gamma carboxyglutamate residue in a patient on warfarin therapy?(NEET PG 2020)</span></span></span></p>",
      "unique_key": "Q4160657",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378978,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Factor 2 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factor 2 would have decreased gamma carboxyglutamate residue in a patient on warfarin therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factors II, VII, IX, X are vitamin k dependent coagulation factors, as their activated by carboxylation of their glutamate residues by enzyme y-glutamyl carboxylase requires vitamin K (reduced form) as a co-factor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This reduced form of vitamin K is constantly oxidized for the reaction to continue. This recycling is done by the enzyme vitamin K epoxide reductase. This enzyme is inhibited by warfarin. Thus, warfarin affects vitamin k dependent factors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/687.png\" style=\"height:583px; width:613px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Factor 11</span></strong><span style=\"font-size:12.0pt\">: Incorrect, Factor XI is not vitamin K-dependent and thus not directly affected by warfarin therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tissue factor</span></strong><span style=\"font-size:12.0pt\">: Incorrect, Tissue factor (Factor III) is a different component of the clotting cascade that acts as a receptor and cofactor for Factor VIIa; it is not a vitamin K-dependent factor and is not affected by warfarin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Factor 5</span></strong><span style=\"font-size:12.0pt\">: Incorrect, Factor V is not dependent on vitamin K for its function, so its activity is not diminished by warfarin therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin therapy impacts the function of vitamin K-dependent clotting factors by inhibiting the recycling of vitamin K, crucial for the carboxylation of these factors. Factor 2 (prothrombin) is one of these affected factors, leading to a reduction in its clotting ability in the presence of warfarin, which is utilized therapeutically to prevent thrombosis.</span></span></span></p>",
      "correct_choice_id": 35187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6972,
      "choices": [
        {
          "id": 27856,
          "text": "<p><span style=\"font-size:12.0pt;\">Systolic blood pressure + Intracranial pressure</span></p>"
        },
        {
          "id": 27857,
          "text": "<p><span style=\"font-size:12.0pt;\">Systolic blood pressure - intracranial pressure</span></p>"
        },
        {
          "id": 27858,
          "text": "<p><span style=\"font-size:12.0pt;\">Mean arterial pressure/intracranial pressure</span></p>"
        },
        {
          "id": 27859,
          "text": "<p><span style=\"font-size:12.0pt;\">Mean arterial pressure - intracranial pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How is cerebral perfusion pressure calculated? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q9143996",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378979,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mean arterial pressure - intracranial pressure</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Cerebral perfusion pressure (CPP) is calculated as mean arterial pressure (MAP) - intracranial pressure (ICP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cerebral perfusion pressure (CPP) is the net pressure gradient that drives oxygen delivery to cerebral tissue. It is the difference between the mean arterial pressure (MAP) and the intracranial pressure (ICP), measured in millimeters of mercury (mm Hg). If ICP values are not readily available, central venous pressure (CVP) may be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal CPP lies between 60- and 80-mm Hg,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cerebral perfusion pressure (CPP) is calculated by subtracting the intracranial pressure (ICP) from the mean arterial pressure (MAP). This measurement is crucial for ensuring adequate blood flow and oxygen delivery to the brain.</span></p>",
      "correct_choice_id": 27859,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5605,
      "choices": [
        {
          "id": 22392,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral fidaxomicin is used for treatment</span></p>"
        },
        {
          "id": 22393,
          "text": "<p><span style=\"font-size:12.0pt;\">It is toxin mediated</span></p>"
        },
        {
          "id": 22394,
          "text": "<p><span style=\"font-size:12.0pt;\">IgM assay is used to confirm the diagnosis</span></p>"
        },
        {
          "id": 22395,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudomembrane consists of leukocytes, fibrin, and cellular debris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with recurrent diarrhea is prescribed a broad-spectrum antibiotic. Which of the following is not true regarding Clostridium difficile infection?</span><span style=\"font-size:10.5pt;\"> &nbsp;(NEET PG 2022)</span></p>",
      "unique_key": "Q6940250",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378980,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) IgM assay is used to confirm the diagnosis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">IgM assay cannot be used to confirm a diagnosis of Clostridium difficile infection. The diagnosis is based on a combination of clinical criteria and detection of toxin in stool samples.</span></li><li><span style=\"font-size:12.0pt;\">C. difficile, a gram-positive anaerobic bacillus, causes Clostridioides (formerly Clostridium) difficile infection (CDI) after ingestion of spores of the organism.</span></li><li><span style=\"font-size:12.0pt;\">The more severe form of the condition is known as pseudomembranous colitis (PMC). It is most commonly associated with prolonged antimicrobial use which interferes with the commensal colonic microflora. The most commonly implicated antibiotics are cephalosporins, ampicillin, and clindamycin.</span></li><li><span style=\"font-size:12.0pt;\">The spores are spread by contact with the feces of affected individuals or asymptomatic carriers.</span></li><li><span style=\"font-size:12.0pt;\">The spores germinate in the small intestine and produce two toxins - toxin A (enterotoxin) and toxin B (cytotoxin). These interfere with the epithelial-cell barrier function and result in diarrhea and pseudomembrane formation.</span></li><li><span style=\"font-size:12.0pt;\">The pseudomembranes appear as small whitish-yellow plaques initially which later coalesce to involve the entire colon wall. It contains necrotic leukocytes, fibrin, and cellular debris. The anamnestic IgG response determines which patients develop the disease or remain asymptomatic.</span></li><li><span style=\"font-size:12.0pt;\">Symptoms include diarrhea, fever, and abdominal pain. The diagnosis is based on a combination of clinical criteria and detection of toxin &nbsp;A Or Toxin B or the organism in stool samples. The mere presence of bacteria in stool does not itend that the patient has the disease as clostridoides difficile is a commensal in the gut. Onlly confirmed toxin detection suggests significant infection with clostridoides difficile &nbsp;This can be done by nucleic acid amplification testing (NAAT methods such as polymerase chain reaction (PCR) or by culture.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Discontinuation of any ongoing antimicrobials and hydration are general measures that are recommended. Oral fidaxomicin or vancomycin is the first-line treatment. Oral metronidazole can be used when these are not available.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Oral fidaxomicin is used for treatment:</strong> This is true; fidaxomicin is a first-line treatment for C. difficile infection, especially in cases of recurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is toxin mediated:</strong> True; the clinical manifestations of CDI are due to the effects of toxins A and B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pseudomembrane consists of leukocytes, fibrin, and cellular debris:</strong> Also true, this describes the characteristic appearance of the pseudomembrane seen in pseudomembranous colitis, a severe form of CDI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clostridium difficile infection is diagnosed primarily through the detection of toxins rather than IgM assays is crucial for appropriate management. This recognition guides the effective use of specific treatments such as oral fidaxomicin or vancomycin, aimed at countering the effects of these toxins and managing the symptoms of the infection.</span></p>",
      "correct_choice_id": 22394,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57188,
      "choices": [
        {
          "id": 228141,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Polycythemia</span></span></span></p>"
        },
        {
          "id": 228142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Interstitial lung disease</span></span></span></p>"
        },
        {
          "id": 228143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Emphysema</span></span></span></p>"
        },
        {
          "id": 228144,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonary vascular disease</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a clinical study on lung function, which condition does not result in decreased diffusion capacity of carbon monoxide (DLCO)?&nbsp;(AIIMS NOV 2016)</span></span></p>",
      "unique_key": "Q5893539",
      "question_audio": null,
      "question_video": null,
      "map_id": 12378981,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: A. Polycythemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Diffusion capacity of carbon monoxide (DLCO) measures how well gases can pass from the air sacs of the lungs into the blood. It is usually decreased in conditions where the alveolar walls are thickened or destroyed, or the blood flow around the alveoli is impaired. In conditions like interstitial lung disease, emphysema, and pulmonary vascular disease, the DLCO is typically reduced due to damage to the lung tissue or blood vessels, reducing gas exchange efficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B. Interstitial lung disease</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Increases the thickness of the alveolar walls, reducing DLCO.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C. Emphysema</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Destroys alveolar walls, reducing the surface area for gas exchange and thereby decreasing DLCO.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Pulmonary vascular disease</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Reduces the blood flow to the lungs&#39; gas exchange areas, lowering DLCO.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Polycythemia, unlike other listed conditions, actually leads to an increased DLCO due to the higher red blood cell count, which improves oxygen-carrying capacity and enhances gas exchange.</span></span></span></p>",
      "correct_choice_id": 228141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24714,
      "choices": [
        {
          "id": 98817,
          "text": "<p><span style=\"font-size:12.0pt;\">T790M mutation</span></p>"
        },
        {
          "id": 98818,
          "text": "<p><span style=\"font-size:12.0pt;\">L858R mutation</span></p>"
        },
        {
          "id": 98819,
          "text": "<p><span style=\"font-size:12.0pt;\">T890M mutation</span></p>"
        },
        {
          "id": 98820,
          "text": "<p><span style=\"font-size:12.0pt;\">M790T mutation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient is diagnosed with non-small cell lung carcinoma (NSCLC). Molecular testing reveals a specific mutation in the EGFR gene. The oncologist is considering using targeted therapy. For which of the following EGFR mutations is Osimertinib most appropriately used to treat non-small cell lung carcinoma?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q7296059",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379172,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. T790M mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Osimertinib</strong> is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that is particularly effective in treating non-small cell lung carcinoma (NSCLC) patients who have developed resistance to first-generation EGFR inhibitors (such as gefitinib or erlotinib) due to the T790M mutation in the EGFR gene. This mutation is a common mechanism of acquired resistance, and Osimertinib is specifically designed to target it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>L858R mutation</strong> is another common EGFR mutation seen in NSCLC. Although Osimertinib can also be used for L858R mutations, it is not specifically indicated as the primary treatment for this mutation. First-generation EGFR inhibitors like gefitinib or erlotinib are often used for L858R mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C</strong>.&nbsp;<strong>T890M mutation</strong> and <strong>Option D</strong>. <strong>M790T mutation</strong> are not recognized mutations associated with EGFR in the context of NSCLC, and there is no evidence to suggest that Osimertinib is used for these mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/02/screenshot-2023-12-02-110037.png\" alt=\"\" width=\"1000\" height=\"457\"></span></p>",
      "correct_choice_id": 98817,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5656,
      "choices": [
        {
          "id": 22596,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        },
        {
          "id": 22597,
          "text": "<p><span style=\"font-size:12.0pt;\">Norepinephrine</span></p>"
        },
        {
          "id": 22598,
          "text": "<p><span style=\"font-size:12.0pt;\">Prazosin</span></p>"
        },
        {
          "id": 22599,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old farmer is bitten by a scorpion. Which of the following acts as a physiological antidote to scorpion venom?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">NEET PG 2019)</span></p>",
      "unique_key": "Q1135080",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379173,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Prazosin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Antidote for scorpion venom: Prazosin acts as a physiological antidote for scorpion venom.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Effects of scorpion venom: hemolytic and neurotoxic</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Symptoms of scorpion venom</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/2_PfZNzEq.jpg\" alt=\"\" width=\"700\" height=\"420\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Physostigmine:&nbsp;</strong>A cholinesterase inhibitor used to treat anticholinergic toxicity. It is not effective against scorpion venom.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Norepinephrine:&nbsp;</strong>A vasopressor used to treat severe hypotension. It is not suitable as an antidote for scorpion venom, which can cause hypertension and other systemic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Atropine:&nbsp;</strong>An anticholinergic drug used to treat bradycardia and certain types of poisonings. It is not effective against scorpion venom.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prazosin acts as a physiological antidote for scorpion venom by counteracting the severe cardiovascular and systemic effects induced by the venom.</span></p>",
      "correct_choice_id": 22598,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9807,
      "choices": [
        {
          "id": 39195,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RAS</span></span></span></p>"
        },
        {
          "id": 39196,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RET</span></span></span></p>"
        },
        {
          "id": 39197,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BRAF</span></span></span></p>"
        },
        {
          "id": 39198,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">p53</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following proto-oncogenes is not implicated in carcinoma of thyroid? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS NOV 2018)</span></span></p>",
      "unique_key": "Q3081906",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379174,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) p53</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">p53 is a tumor suppressor gene, not a proto-oncogene like other 3 options.</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Proto-oncogenes are genes that, when mutated or overexpressed, have the potential to cause normal cells to become cancerous by promoting cell growth and division. On the other hand, tumor suppressor genes like p53 work to prevent uncontrolled cell growth. The p53 gene, often referred to as the &quot;guardian of the genome,&quot; plays a crucial role in regulating the cell cycle, DNA repair, and apoptosis (programmed cell death). When p53 is mutated, it can no longer effectively suppress tumor growth, leading to the development of cancer. However, p53 is not categorized as a proto-oncogene and is not directly implicated in thyroid carcinoma as an oncogenic driver.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Selected oncogenes, Their Mode of Activation, and Associated Human Tumors</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-104500.png\" style=\"height:961px; width:1000px\" /></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-180427_9gWSV27.png\" style=\"height:287px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotrans pathologic basis of disease, 8<sup>th</sup> edition, Pg no 520</span></strong></span></span></p>",
      "correct_choice_id": 39198,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1218,
      "choices": [
        {
          "id": 4867,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior ethmoidal canal</span></p>"
        },
        {
          "id": 4868,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior ethmoidal canal</span></p>"
        },
        {
          "id": 4869,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic nerve</span></p>"
        },
        {
          "id": 4870,
          "text": "<p><span style=\"font-size:12.0pt;\">Cribriform plate</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the structure marked in the CT scan? (INCET MAY 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-138.jpg\" alt=\"\" width=\"358\" height=\"359\"></span></p>",
      "unique_key": "Q9902827",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379175,
      "difficulty_level": "intermediate",
      "subjects_id": [
        17
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Anterior ethmoidal canal &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\">Anterior ethmoidal canal is noted by the marked arrows. </span><span style=\"font-size:12.0pt;\">The anterior ethmoidal canal can be recognized by the fact that it lies below the ethmoidal air cell roof. To prevent bleeding from this vessel during sinus procedures, it is crucial to recognize that the anterior ethmoidal artery runs via this canal. </span><span style=\"font-size:10.5pt;\">Maxillary sinus is noted in this view hence suggesting anterior plane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> The posterior ethmoidal artery, vein, and nerve pass via the ethmoid bones posterior ethmoid canal or foramen. Due to the fact that this image is a coronal section taken at the level of the anterior ethmoidal cells, it cannot be seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> The optic nerve can be identified as an oval intraorbital structure in the coronal sections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> The cribriform plate is a sieve-like structure between the nasal cavity and the anterior cranial fossa. It is part of the ethmoid bone and as it is pierced by the olfactory nerve fibers. Crista Galli is also a part of ethmoid bone that projects superiorly from the cribriform plate. It provides attachment for the falx cerebri.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">The anterior ethmoidal canal is critical to identify during sinus procedures to avoid complications such as bleeding from the anterior ethmoidal artery. It is located below the roof of the ethmoidal air cells and anterior to the posterior ethmoidal canal.</span></p>",
      "correct_choice_id": 4867,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5215,
      "choices": [
        {
          "id": 20832,
          "text": "<p><span style=\"font-size:12.0pt;\">Battle sign</span></p>"
        },
        {
          "id": 20833,
          "text": "<p><span style=\"font-size:12.0pt;\">Bezold abscess</span></p>"
        },
        {
          "id": 20834,
          "text": "<p><span style=\"font-size:12.0pt;\">Mastoiditis</span></p>"
        },
        {
          "id": 20835,
          "text": "<p><span style=\"font-size:12.0pt;\">Griesinger sign</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person who met with an accident, and suffered from a skull fracture presents with the following finding. Identify this clinical finding. (NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/2_lYJPYiL.jpg\" alt=\"\" width=\"300\" height=\"298\"></span></p>",
      "unique_key": "Q9014837",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379176,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Battle sign</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows Battle's sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is retroarticular or mastoid ecchymosis that typically results from fracture of middle cranial fossa following head trauma. Battle sign is prominent when there is a fracture of the petrous temporal bone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> Bezold abscess is a complication of acute otomastoiditis where the infection extends into the infratemporal fossa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Mastoiditis presents as retro-auricular redness, swelling which is painful.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> The Griesinger sign refers to edema of the postauricular soft tissues overlying the mastoid process as a result of thrombosis of the mastoid emissary vein. It is a complication of acute otomastoiditis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Battle's sign is a significant diagnostic clue in trauma patients, signaling a possible basilar skull fracture. Recognition of this sign should prompt further diagnostic imaging and careful neurologic assessment to manage potential complications associated with such fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 20832,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13962,
      "choices": [
        {
          "id": 55809,
          "text": "<p><span style=\"font-size:12.0pt;\">Exudative RD</span></p>"
        },
        {
          "id": 55810,
          "text": "<p><span style=\"font-size:12.0pt;\">Traction RD</span></p>"
        },
        {
          "id": 55811,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhegmatogenous RD</span></p>"
        },
        {
          "id": 55812,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal dialysis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">During an ocular examination, the ophthalmologist observes the presence of the shifting fluid sign in the patient. This finding suggests that the patient might have which of the following conditions? (NEET PG 2020)</span></p>",
      "unique_key": "Q3833495",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379177,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Exudative RD</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Shifting fluid is a hallmark feature of serous or exudative retinal detachment.</span></li><li><span style=\"font-size:12.0pt;\">In serous retinal detachment, there is subretinal accumulation of serous fluid mostly due to breakdown in blood-retinal barrier.</span></li><li><span style=\"font-size:12.0pt;\">Fluid shifts to the dependent portion when head position is altered.</span></li><li><span style=\"font-size:12.0pt;\">Serous retinal detachment has a smooth convex configuration and lacks a retinal tear or preretinal traction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Rhegmatogenous</strong> <strong>RD</strong> presents with tobacco dust in anterior vitreous, substantial vitreous blood or inflammatory cells, and retinal breaks.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Traction</strong> <strong>RD</strong> has a concave configuration, absent breaks, and severely reduced retinal mobility.</span></li><li><span style=\"font-size:12.0pt;\">Shifting fluid is absent in traction RD.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Traction RD:</strong> Tractional retinal detachment is caused by fibrovascular proliferation and contraction of epiretinal membranes, leading to mechanical traction on the retina. It has a concave configuration and lacks shifting fluid due to the tethering of the retina by fibrous tissue. Retinal mobility is severely reduced, and retinal breaks are usually absent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Rhegmatogenous RD:</strong> Rhegmatogenous retinal detachment occurs due to a retinal tear or hole that allows vitreous fluid to enter the subretinal space. It presents with signs such as tobacco dust (Shafer's sign) in the anterior vitreous, substantial vitreous blood, inflammatory cells, and visible retinal breaks. Shifting fluid is not a characteristic feature of rhegmatogenous RD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Retinal Dialysis:</strong> Retinal dialysis is a type of retinal tear that typically occurs at the ora serrata, where the retina is particularly thin and prone to tearing. It is most often seen in younger patients or those who have experienced trauma. Shifting fluid is not a specific feature of retinal dialysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/picture94.jpg\" alt=\"\" width=\"1000\" height=\"493\"></p>",
      "correct_choice_id": 55809,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5754,
      "choices": [
        {
          "id": 22987,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st stage</span></span></span></p>"
        },
        {
          "id": 22988,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2nd stage</span></span></span></p>"
        },
        {
          "id": 22989,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3rd stage</span></span></span></p>"
        },
        {
          "id": 22990,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4th stage</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A primigravida came with 6 cm cervical dilatation and a contraction rate of 3/10 minutes. Which stage of labor is she in?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q9109544",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379178,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1st stage</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient is in the 1st stage of labor, which is defined as the onset of true labor pain until the full dilation of the cervix. The 1st stage of labor can be further classified as:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latent phase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cervical dilation of less than 5 cm.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Active phase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cervical dilation of 5 cm or more.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Earlier, this cutoff for the active phase was considered at 4 cm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 2nd stage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The second stage of labor begins with complete cervical dilation and ends with the delivery of the fetus. Since the cervix is not fully dilated (10 cm), the patient is not in the second stage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 3rd stage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The third stage of labor is characterized by the delivery of the placenta. The patient is not in this stage as the fetus has not yet been delivered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 4th stage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The fourth stage is a stage of observation for at least an hour after the full expulsion of the placenta. The patient is not in this stage as the delivery process is still ongoing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The 1st stage of labor, which involves cervical dilation from the onset of true labor pain until full dilation, is divided into latent and active phases, with the active phase beginning at 5 cm dilation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 155, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22987,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21079,
      "choices": [
        {
          "id": 84280,
          "text": "<p><span style=\"font-size:12.0pt;\">Medial umbilical ligament</span></p>"
        },
        {
          "id": 84281,
          "text": "<p><span style=\"font-size:12.0pt;\">Median umbilical ligament</span></p>"
        },
        {
          "id": 84282,
          "text": "<p><span style=\"font-size:12.0pt;\">Meckel's diverticulum</span></p>"
        },
        {
          "id": 84283,
          "text": "<p><span style=\"font-size:12.0pt;\">Ligamentum teres</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which adult structure is derived from the embryological remnant marked as A in the diagram? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/12/whatsapp-image-2023-06-12-at-19012101101022.jpg\" alt=\"\" width=\"300\" height=\"262\"></span></p>",
      "unique_key": "Q2096473",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379179,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Median umbilical ligament</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marked structure A is the allantois, which forms the urachus, which in turn gives rise to the median umbilical ligament.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The median umbilical ligament represents the remnant of the urachus (also known as the median umbilical fold). The urachus is a tubular structure that connects the fetal bladder to the umbilical cord and allows for the drainage of urine produced by the fetal kidneys into the amniotic fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">After birth, the urachus becomes non-functional and fibroses to form the median umbilical ligament. It extends from the apex of the bladder to the umbilicus within the median umbilical fold.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows an embryo at the end of the third week.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/14/screenshot-2024-05-14-142904.png\" alt=\"\" width=\"400\" height=\"310\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Medial umbilical ligament</strong>: These are the remnants of the occluded parts of the umbilical arteries. In fetal life, the umbilical arteries arise from the internal iliac arteries and pass to the umbilical cord, carrying deoxygenated blood from the fetus to the placenta.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In the adult, they persist as the medial umbilical ligaments, which are paired fibrous bands on the inner surface of the anterior abdominal wall, running from the bladder to the umbilicus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Meckel's diverticulum</strong>: Meckel's diverticulum arises from the incomplete obliteration of the vitelline duct (or omphalomesenteric duct), which connects the yolk sac to the midgut lumen during embryonic development. It usually disappears by the 7th week of embryonic life.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">If a portion of the vitelline duct remains, it can manifest as a Meckel's diverticulum. It's found in approximately 2% of the population and is often described by the \"rule of 2s\" - 2 inches long, 2 feet from the ileocecal valve, 2% of the population, and can present with two types of epithelia (gastric and pancreatic).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ligamentum teres (Round ligament of the liver)</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The ligamentum teres represents the obliterated remnant of the left umbilical vein. During fetal development, the left umbilical vein carries oxygenated blood from the placenta directly to the fetal heart, bypassing the liver through the ductus venosus.</span></li><li><span style=\"font-size:12.0pt;\">After birth, the need for this shunt ceases, and the ductus venosus along with the left umbilical vein close up. The ligamentum teres runs in the free margin of the falciform ligament, connecting the umbilicus to the anterior aspect of the liver.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/06/screenshot-2023-11-06-183107.jpg\" alt=\"\" width=\"1000\" height=\"404\"></p>",
      "correct_choice_id": 84281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54676,
      "choices": [
        {
          "id": 218169,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-c, 3-b, 4-d</span></p>"
        },
        {
          "id": 218170,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-b, 3-c, 4-d</span></p>"
        },
        {
          "id": 218171,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
        },
        {
          "id": 218172,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-a, 4-d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following&nbsp;(INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/24/screenshot-2024-08-24-104329.png\" alt=\"\" width=\"1000\" height=\"213\"></span></p>",
      "unique_key": "Q7376940",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379180,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) 1-a, 2-b, 3-c, 4-d</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Eonism:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>a. Sexual gratification by cross-dressing. </strong>This term is used to describe individuals who derive sexual pleasure from dressing in clothes traditionally worn by the opposite gender.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Frotteurism:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>b. The act of rubbing one's genitals against a non-consenting person,</strong> usually in a crowded place, such as public transport. It is considered a paraphilic disorder.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Necrophilia:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>c. Sexual stimulation by corpses</strong>. This is a rare and extreme paraphilia where individuals are sexually aroused by deceased bodies.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Algolagnia:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>d. Sexual gratification in inflicting or suffering pain</strong>. This can involve either sadism (inflicting pain) or masochism (receiving pain) as part of sexual activity.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eonism is sexual gratification by cross-dressing, frotteurism involves rubbing genitals against a non-consenting person, necrophilia is sexual stimulation by corpses, and algolagnia involves sexual gratification from inflicting or suffering pain.</span></p>",
      "correct_choice_id": 218170,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57189,
      "choices": [
        {
          "id": 228145,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Immediate fibrinolysis</span></span></span></p>"
        },
        {
          "id": 228146,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Aspirin with heparin</span></span></span></p>"
        },
        {
          "id": 228147,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Emergent coronary artery bypass grafting (CABG)</span></span></span></p>"
        },
        {
          "id": 228148,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Observation with serial ECG monitoring</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 58-year-old man with a history of hypertension and hyperlipidemia presents to the emergency department with crushing chest pain that started 3 hours ago while he was watching television. The pain radiates to his left arm and is associated with nausea and diaphoresis. His vital signs are: blood pressure 150/90 mm Hg, heart rate 95 beats per minute, and respiratory rate 18 breaths per minute. Physical examination reveals no jugular venous distension, clear lungs, and a normal S1 and S2 without murmurs. An ECG shows ST depression and T wave inversion in the anterior chest leads. Troponin levels are elevated. What is the best initial management approach for this patient?</span></span></span></p>",
      "unique_key": "Q5219129",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379181,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Aspirin with heparin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">This patient&#39;s clinical presentation, ECG findings of ST depression and T wave inversion, and elevated troponin levels indicate Non-ST Elevation Myocardial Infarction (NSTEMI). NSTEMI is typically caused by a subtotal occlusion of a coronary artery with a platelet-rich thrombus leading to ischemia. The initial management includes dual antiplatelet therapy (DAPT) such as aspirin and anticoagulation with low molecular weight heparin (LMWH). These treatments help prevent further thrombus formation and reduce the risk of distal embolization. After stabilization, the patient should undergo coronary angiography (CAG) to assess the extent of coronary artery disease and guide further management, such as percutaneous coronary intervention (PCI).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Immediate fibrinolysis</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Fibrinolysis is reserved for ST-Elevation Myocardial Infarction (STEMI) with complete coronary occlusion. In NSTEMI, where the thrombus is usually platelet-rich and partial, fibrinolysis is ineffective and increases the risk of bleeding without providing benefit.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Emergent coronary artery bypass grafting (CABG)</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">CABG is considered for severe multivessel disease or left main coronary artery involvement, often after failed PCI or in cases with specific anatomical considerations. It is not the immediate treatment for NSTEMI without prior evaluation with coronary angiography.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Observation with serial ECG monitoring</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Observation alone is insufficient in managing NSTEMI due to the risk of ongoing ischemia and potential progression to myocardial infarction. Immediate DAPT and anticoagulation are critical to stabilizing the patient and reducing further cardiac events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">NSTEMI is characterized by subtotal occlusion and platelet-rich thrombosis leading to myocardial ischemia. Immediate management includes dual antiplatelet therapy and anticoagulation, followed by coronary angiography to determine the need for revascularization. Fibrinolysis is contraindicated in NSTEMI, highlighting the importance of distinguishing it from STEMI in acute management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/14/picture3.jpg\" style=\"height:427px; width:600px\" /></span></span></span></p>",
      "correct_choice_id": 228146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11046,
      "choices": [
        {
          "id": 44150,
          "text": "<p><span style=\"font-size:18px;\">0.66/10,000 population</span></p>"
        },
        {
          "id": 44151,
          "text": "<p><span style=\"font-size:18px;\">0.66/1 lakh population</span></p>"
        },
        {
          "id": 44152,
          "text": "<p><span style=\"font-size:18px;\">9.7/10,000 population</span></p>"
        },
        {
          "id": 44153,
          "text": "<p><span style=\"font-size:18px;\">9.7/1 lakh population</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Dr. Mehta, Public health expert who works extensively with the National Leprosy Eradication Programme (NLEP) in India. In a meeting with local health workers in 2017, he has shared the data and progress made in controlling leprosy. He mentions the crucial statistic of the Annual New Case Detection Rate (ANCDR) as of March 31, 2016, to give a snapshot of the magnitude of new leprosy cases detected. This rate helps in understanding the effectiveness of ongoing programs and strategies. What value did Dr. Mehta share as the ANCDR for leprosy for that specific year? </strong><i><strong>[AIIMS MAY 2017]</strong></i></span></p>",
      "unique_key": "Q6529952",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379222,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) 9.7/1 lakh population</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">During the 2015-2016 period, India recorded an annual new case detection rate (ANCDR) for leprosy at 9.7 per 100,000 people.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Annual New Case Detection Rate (ANCDR):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">An important Indicator being used under the National Leprosy Eradication Program&nbsp;</span></li><li><span style=\"font-size:18px;\">Indicator is calculated at the end of March every year, wherein New Cases detected during the period April (Previous Calendar year) and March (current year) is used</span></li><li><span style=\"font-size:18px;\">ANCDR - 2015-16: 9.71 per 100,000 population</span></li><li><span style=\"font-size:18px;\"><strong>ANCDR - 2021-22: 5.52 per 100,000 population</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The ANCDR is a pivotal indicator in disease surveillance and control programs, helping public health officials and stakeholders understand the scale of new cases and the impact of interventions.</span></li><li><span style=\"font-size:18px;\">For leprosy in India, maintaining a keen understanding of this rate is essential for achieving the goals of the National Leprosy Eradication Programme.</span></li></ul>",
      "correct_choice_id": 44153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7580,
      "choices": [
        {
          "id": 30288,
          "text": "<p><span style=\"font-size:12pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 30289,
          "text": "<p><span style=\"font-size:12pt;\">Metabolic syndrome</span></p>"
        },
        {
          "id": 30290,
          "text": "<p><span style=\"font-size:12pt;\">Addisons disease</span></p>"
        },
        {
          "id": 30291,
          "text": "<p><span style=\"font-size:12pt;\">Hyperparathyroidism</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A female patient with a BMI of 35 kg/m2 presents to you with a skin lesion in the axilla as shown below. Which of the following condition is she most likely to be suffering from?&nbsp;(NEET PG 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-1331_TeIe1ev.jpg\" alt=\"\" width=\"300\" height=\"380\"></p>",
      "unique_key": "Q3696021",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379223,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Metabolic syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The skin lesion shown in the image of <strong>axilla</strong> with <strong>velvety textured</strong> skin is indicative of <strong>Acanthosis nigricans</strong>. In this case, the patient is most likely suffering from <strong>Metabolic syndrome</strong> based on the diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Acanthosis nigricans</strong></span></p><ul><li><span style=\"font-size:12pt;\">It is characterized by <strong>thickened, gray-brown velvety plaques</strong> seen in <strong>flexural</strong> areas such as the back of the neck, axillae, inframammary creases, waist, and groin.</span></li><li><span style=\"font-size:12pt;\">The release of <strong>epidermal growth factors</strong> in the affected area is the causal mechanism.</span></li><li><span style=\"font-size:12pt;\">Acanthosis Nigricans may be benign or linked to a malignancy.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-133942.png\" alt=\"\" width=\"900\" height=\"101\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Acanthosis nigricans can also be seen in the following:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Multiple <strong>seborrhoeic keratoses</strong></span></li><li><span style=\"font-size:12pt;\">Drugs like <strong>nicotinic acid</strong> (Use for hyperlipidaemia treatment)</span><ul><li><span style=\"font-size:12pt;\">Other conditions associated with metabolic syndrome include <strong>polycystic ovarian</strong> syndrome, sleep apnea &amp; <strong>non-alcoholic fatty liver disease</strong>.</span></li><li><span style=\"font-size:12pt;\">The condition is managed by <strong>dietary &amp; lifestyle</strong> modifications.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Hypothyroidism:</strong></span></p><ul><li><span style=\"font-size:12pt;\">Hypothyroidism primarily manifests with symptoms such as <strong>fatigue, weight gain, cold intolerance, bradycardia, alopecia and dry skin</strong>. It doesn't typically lead to velvety skin changes like Acanthosis nigricans.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Addisons disease:</strong></span></p><ul><li><span style=\"font-size:12pt;\">Addison's disease, or <strong>primary adrenal insufficiency</strong>, leads to symptoms like <strong>fatigue, weight loss, low blood pressure, salt craving, and hyperpigmentation.</strong> However, the hyperpigmentation associated with Addison's is <strong>more diffuse</strong> and not restricted to velvety changes in the axilla.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Hyperparathyroidism:</strong></span></p><ul><li><span style=\"font-size:12pt;\">This condition primarily results from an overproduction of parathyroid hormone (PTH), leading to <strong>elevated calcium levels</strong> in the blood. Symptoms include <strong>kidney stones, bone pain, and fatigue</strong>. Skin changes like Acanthosis nigricans are not a typical presentation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">E<strong>ducational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Acanthosis nigricans</strong> is marked by a <strong>velvety darkening</strong> of the skin in body <strong>folds.</strong></span></li><li><span style=\"font-size:12pt;\">There's a notable link between <strong>obesity, acanthosis nigricans</strong>, and <strong>metabolic syndrome</strong>, with the latter condition often being a visible indicator of <strong>insulin resistance</strong>.</span></li><li><span style=\"font-size:12pt;\">Recognizing <strong>acanthosis nigricans</strong> is vital as it can be a marker of underlying <strong>systemic issues</strong> that may require comprehensive <strong>medical evaluation.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>References </strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrisons principle s of internal medicine 21<sup>st</sup> edition Page no 390, 2933,2934, 2936, 2970, 2971, 3086, 3150, 3151, 3154, 3155, 3156, 3173, 3175</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Current Medical Diagnosis &amp; Treatment 2022 Page no 1157</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rook's Textbook of Dermatology, 9th edition, Chapter 147, Page no 147.14-147.15</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Williams Gynecology, 3rd edition, Page no 391</strong></span></p>",
      "correct_choice_id": 30289,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24676,
      "choices": [
        {
          "id": 98665,
          "text": "<p><span style=\"font-size:12.0pt;\">Midline lethal granuloma</span></p>"
        },
        {
          "id": 98666,
          "text": "<p><span style=\"font-size:12.0pt;\">Foreign body granuloma</span></p>"
        },
        {
          "id": 98667,
          "text": "<p><span style=\"font-size:12.0pt;\">Phycomycosis</span></p>"
        },
        {
          "id": 98668,
          "text": "<p><span style=\"font-size:12.0pt;\">IgG4 granuloma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old man has arrived with a gradual swelling on the left side of his face persisting for two weeks. He had a prior incident of trauma involving wood, which occurred two months ago. A contrast-enhanced CT scan of the nasal passages and paranasal sinuses reveals a mass within the subcutaneous tissue of the left cheek. Examination of a tissue sample obtained via biopsy indicates the presence of a foreign body granuloma, with positive staining observed using PAS and GMS methods. What is the likely diagnosis? (</span>INICET May 2023)</p>",
      "unique_key": "Q6239959",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379224,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p style=\"text-align:justify;\"><strong>Ans. C) Phycomycosis</strong></p><p style=\"text-align:justify;\">The given clinical scenario points to a diagnosis of Phycomycosis /Mucormycosis. GMS positive confirms this.</p><p style=\"text-align:justify;\">It is fungal infection which may prove rapidly fatal. It is seen in uncontrolled diabetics or in those taking immunosuppressive drugs.&nbsp;</p><p style=\"text-align:justify;\"><strong>Other Options:</strong></p><p style=\"text-align:justify;\"><strong>Option A. Midline lethal granuloma</strong>: This is a term historically used to describe aggressive midline facial granulomatous diseases, often linked to conditions like granulomatosis with polyangiitis (Wegener's granulomatosis). It does not fit the biopsy findings or clinical scenario described here.</p><p style=\"text-align:justify;\"><strong>Option B. Foreign body granuloma</strong>: Although the biopsy indicates the presence of a foreign body granuloma, the positive PAS and GMS staining suggests a fungal etiology, which is characteristic of Phycomycosis.</p><p style=\"text-align:justify;\"><strong>Option D. IgG4 granuloma</strong>: This is associated with IgG4-related disease, which presents with different clinical and histopathological findings, not typically involving PAS and GMS positive fungal elements.</p><p style=\"text-align:justify;\"><strong>Educational Objective:</strong></p><p style=\"text-align:justify;\">Phycomycosis should be considered in patients with a history of trauma, swelling, and positive fungal stains (PAS and GMS), particularly if they have underlying conditions like diabetes or immunosuppression.</p><p style=\"text-align:justify;\">&nbsp;</p>",
      "correct_choice_id": 98667,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1928,
      "choices": [
        {
          "id": 7705,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">tRNA of Alanine</span></span></span></p>"
        },
        {
          "id": 7706,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">U6 SnRNA</span></span></span></p>"
        },
        {
          "id": 7707,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">mRNA for Histone</span></span></span></p>"
        },
        {
          "id": 7708,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SiRNA</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following does not require 5&#39; capping? (</span></span></span>AIIMS May 2018)</p>",
      "unique_key": "Q8775042",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379225,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) tRNA of Alanine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5&rsquo; capping - Eukaryotic mRNAs are all &lsquo;capped&rsquo; at the 5&prime; terminus by 7-methyl guanosine triphosphate. An unusual 5&rsquo; to 5&prime; triphosphate bridge is seen. This <strong>happens inside the nucleus</strong>. <strong>The cap is useful in recognition of mRNA by the translating machinery and in prevention of degradation by exonucleases. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Poly-A Tailing at 3&prime; End - </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The 3&rsquo; terminus is polyadenylated in the nucleoplasm. This</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">poly-A tail may be <strong>20 to 250 nucleotides long</strong>. This <strong>tail protects mRNA from attack by 3&prime; exonuclease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Note:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">tRNA do not require capping at 5&rsquo; end.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. U6 SnRNA:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Function:</span></strong><span style=\"font-size:12.0pt\"> U6 snRNA is part of the spliceosome complex involved in RNA splicing.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Modification:</span></strong><span style=\"font-size:12.0pt\"> U6 snRNA is not typically capped with 7-methyl guanosine but may undergo other modifications.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. mRNA for Histone:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Function:</span></strong><span style=\"font-size:12.0pt\"> Histone mRNAs are unique in that they typically do not have poly-A tails but do require 5&#39; capping.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Modification:</span></strong><span style=\"font-size:12.0pt\"> Despite lacking poly-A tails, histone mRNAs still undergo 5&#39; capping.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. SiRNA (Small interfering RNA):</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Function:</span></strong><span style=\"font-size:12.0pt\"> SiRNAs are involved in the RNA interference pathway, leading to the degradation of target mRNAs.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Modification:</span></strong><span style=\"font-size:12.0pt\"> SiRNAs are typically not capped at the 5&#39; end as they are processed from longer double-stranded RNA precursors.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">tRNA, including tRNA for alanine, does not require 5&#39; capping. This modification is specific to mRNAs and some snRNAs, playing a critical role in mRNA stability and translation.</span></span></span></p>",
      "correct_choice_id": 7705,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43261,
      "choices": [
        {
          "id": 172711,
          "text": "<p><span style=\"font-size:12pt;\">A-1,B-3,C-2,D-4</span></p>"
        },
        {
          "id": 172712,
          "text": "<p><span style=\"font-size:12pt;\">A-4,B-3,C-2,D-1</span></p>"
        },
        {
          "id": 172713,
          "text": "<p><span style=\"font-size:12pt;\">A-1,B-2,C-4,D-3</span></p>"
        },
        {
          "id": 172714,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1,B-2,C-3,D-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following poison and site of action :&nbsp;</span>(INICET NOVEMBER 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-095846.JPG\" alt=\"\" width=\"748\" height=\"311\"></span></p>",
      "unique_key": "Q5225954",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379226,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. A-1,B-2,C-3,D-4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The correct matches for the poisons and their primary sites of action, based on typical pharmacological effects, are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Datura</strong>: Acts on the CNS (Central Nervous System) due to its content of tropane alkaloids which cause anticholinergic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Nicotine</strong>: Primarily affects the cardiovascular system (CVS), influencing heart rate and blood pressure through its stimulant effects on nicotinic acetylcholine receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Nitric Acid</strong>: Its primary contact effect is on the skin, causing severe burns upon exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Nux Vomica</strong>: Contains strychnine, which affects the spinal cord (spine), leading to heightened reflex excitability and convulsions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational objective :</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>A-1</strong>: Datura acts on the CNS.</span></li><li><span style=\"font-size:12pt;\"><strong>B-2</strong>: Nicotine affects the CVS.</span></li><li><span style=\"font-size:12pt;\"><strong>C-3</strong>: Nitric Acid affects the Skin.</span></li><li><span style=\"font-size:12pt;\"><strong>D-4</strong>: Nux Vomica acts on the Spine.</span></li></ul>",
      "correct_choice_id": 172714,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11249,
      "choices": [
        {
          "id": 44962,
          "text": "<p><span style=\"font-size:12.0pt;\">It is faster than AV nodal pathway</span></p>"
        },
        {
          "id": 44963,
          "text": "<p><span style=\"font-size:12.0pt;\">It is slower than AV nodal pathway</span></p>"
        },
        {
          "id": 44964,
          "text": "<p><span style=\"font-size:12.0pt;\">Leads to short PR interval</span></p>"
        },
        {
          "id": 44965,
          "text": "<p><span style=\"font-size:12.0pt;\">Leads to prolonged QRS duration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the false statement about the bundle of Kent? (NEET PG 2019)</span></p>",
      "unique_key": "Q9288286",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379227,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. It is slower than AV nodal pathway</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The false statement about the bundle of Kent is that it is slower than the AV nodal pathway. In fact, the bundle of Kent provides a rapid conduction pathway between the atrium and the ventricle, bypassing the AV node. This pathway allows for faster conduction than the AV nodal pathway due to the nature of the myocardial fibers involved and the lack of delay that normally occurs at the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It is faster than the AV nodal pathway</strong>: This statement is actually true. The bundle of Kent facilitates faster electrical conduction from the atria to the ventricles by bypassing the slower AV node, contributing to the clinical manifestations of pre-excitation syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Leads to a short PR interval</strong>: This is true. The rapid conduction via the bundle of Kent results in premature activation of the ventricles, reflected as a shortened PR interval on an electrocardiogram.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leads to a prolonged QRS duration</strong>: This is also true. The activation of ventricular myocardium via the accessory pathway occurs in a less synchronized manner compared to normal conduction through the His-Purkinje system, leading to a broader and prolonged QRS complex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bundle of Kent is an accessory pathway connecting atrium and ventricle with conduction through Na+ channels leading to bypass of physiological AV conduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cardiology/WPW</strong></span></p>",
      "correct_choice_id": 44963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14368,
      "choices": [
        {
          "id": 57433,
          "text": "<p><span style=\"font-size:12.0pt;\">GIST</span></p>"
        },
        {
          "id": 57434,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
        },
        {
          "id": 57435,
          "text": "<p><span style=\"font-size:12.0pt;\">Hodgkins lymphoma</span></p>"
        },
        {
          "id": 57436,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old female patient presents to the hospital with complaints of abdominal pain and discomfort for the past few months. The patient also reported experiencing weight loss and loss of appetite. On evaluation, a mass is palpable in the upper abdomen, and an endoscopy shows an ulcerated lesion in the stomach. A biopsy of the lesion is taken and sent for immunohistochemistry. The biopsy sample is found to be positive for CD117 and negative for LCA, cytokeratin, and S100. Based on these findings. What is the most likely diagnosis?</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q9968504",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379228,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) GIST</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation and the biopsy results suggest the possibility of gastrointestinal stromal tumors (GIST). GIST is the most common mesenchymal tumor of the abdomen, and it typically arises from the interstitial cells of Cajal or the pacemaker cells of the gastrointestinal muscularis propria. GISTs are often associated with symptoms of mass effect, such as abdominal pain and discomfort, and can lead to weight loss and loss of appetite. The diagnosis of GIST is confirmed by immunohistochemistry, which typically shows positivity for KIT (CD117) detectable in Cajal cells. Other immunohistochemical markers such as LCA, cytokeratin, and S100 are negative. Treatment options for GIST may include surgery, radiation therapy, or targeted therapy with tyrosine kinase inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adenocarcinoma</strong>: Adenocarcinoma is a common type of cancer that can occur in various organs, including the stomach. However, the immunohistochemistry findings mentioned in the question (positive for CD117 and negative for LCA, cytokeratin, and S100) are not characteristic of adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hodgkins lymphoma</strong>: Hodgkin's lymphoma is a type of lymphoma that typically presents with enlarged lymph nodes and is characterized by the presence of Reed-Sternberg cells. The immunohistochemistry findings mentioned in the question are not consistent with Hodgkin's lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Squamous cell carcinoma</strong>: Squamous cell carcinoma is commonly associated with the epithelial lining of organs, and its diagnosis would typically involve positive staining for cytokeratin. The immunohistochemistry findings mentioned in the question (negative for cytokeratin) do not support the diagnosis of squamous cell carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">GISTs are mesenchymal tumors that typically occur in the gastrointestinal tract. They often express CD117 (c-kit), a marker commonly associated with GIST. The negative staining for LCA (Leukocyte Common Antigen), cytokeratin, and S100 helps rule out other possibilities and supports the diagnosis of GIST.</span></p>",
      "correct_choice_id": 57433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57190,
      "choices": [
        {
          "id": 228149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Graves&#39; disease</span></span></span></p>"
        },
        {
          "id": 228150,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Toxic multinodular goiter</span></span></span></p>"
        },
        {
          "id": 228151,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Toxic adenoma</span></span></span></p>"
        },
        {
          "id": 228152,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroiditis</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man presents with palpitations, weight loss, and heat intolerance over the past three months. Physical examination reveals a palpable nodule on the right side of his neck and a mild tremor of his hands. Laboratory tests show elevated free T4 and suppressed TSH levels. A radioactive iodine uptake (RAIU) scan is performed, report shown below. Based on these findings, which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/14/picture2_8YSW0tg.jpg\" style=\"height:193px; width:300px\" /></span></span></p>",
      "unique_key": "Q4095748",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379229,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: C. Toxic adenoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The clinical presentation and radioactive iodine uptake scan findings are consistent with a toxic adenoma, also known as a hyperfunctioning solitary thyroid nodule. Toxic adenomas are autonomous nodules that produce thyroid hormone independently of TSH regulation, leading to suppression of the rest of the thyroid gland. This condition typically presents with symptoms of hyperthyroidism, such as weight loss, heat intolerance, and palpitations, and is confirmed by a RAIU scan showing increased uptake confined to the adenoma with suppression of uptake in the surrounding thyroid tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Graves&#39; disease:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Graves&#39; disease is characterized by diffuse increased uptake throughout the entire thyroid gland on a RAIU scan due to thyroid-stimulating immunoglobulins. It does not present as a solitary focus of increased uptake with suppression of the rest of the gland.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Toxic multinodular goiter:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> This condition involves multiple hyperfunctioning nodules within the thyroid gland, resulting in patchy areas of increased uptake on the RAIU scan. It differs from toxic adenoma, which shows a solitary area of increased uptake.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Thyroiditis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Thyroiditis typically leads to decreased or absent iodine uptake on a RAIU scan due to inflammation and release of preformed thyroid hormone rather than increased production. It is not associated with a focal area of increased uptake.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Toxic adenoma is characterized by a solitary hyperfunctioning thyroid nodule that autonomously produces thyroid hormone, leading to suppression of TSH and suppression of the rest of the thyroid tissue on a RAIU scan. It presents with symptoms of hyperthyroidism and is confirmed by localized increased uptake on imaging.</span></span></span></p>",
      "correct_choice_id": 228151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11706,
      "choices": [
        {
          "id": 46790,
          "text": "<p><span style=\"font-size:12.0pt;\">TB</span></p>"
        },
        {
          "id": 46791,
          "text": "<p><span style=\"font-size:12.0pt;\">Neisseria gonorrhea</span></p>"
        },
        {
          "id": 46792,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryptococcus</span></p>"
        },
        {
          "id": 46793,
          "text": "<p><span style=\"font-size:12.0pt;\">Coxsackie</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient comes to ED with fever and headache. On examination, he has neck stiffness. CSF analysis was done and it shows the following findings. Most likely diagnosis is: (AIIMS NOV 2018)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Opening pressure- increased</span></li><li><span style=\"font-size:12.0pt;\">Proteins- mildly increased</span></li><li><span style=\"font-size:12.0pt;\">Glucose  normal</span></li><li><span style=\"font-size:12.0pt;\">Lymphocytes- increased</span></li></ul>",
      "unique_key": "Q2624838",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379230,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Coxsackie</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The CSF findings indicative of increased lymphocytes, normal glucose levels, and mildly increased protein are characteristic of viral meningitis. Coxsackie virus, a common cause of viral meningitis, often presents with these CSF findings. The typical profile of viral meningitis includes normal glucose levels, which helps differentiate it from bacterial, fungal, and tuberculous meningitis where glucose levels are often decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. TB:&nbsp;</strong>Tuberculous meningitis typically shows low glucose, high protein, and a mixed cellular response in the CSF, which does not match the patient's CSF profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Neisseria gonorrhea:&nbsp;</strong>Generally causes bacterial meningitis with a different CSF profilelow glucose, high protein, and predominantly polymorphonuclear cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cryptococcus:&nbsp;</strong>Fungal meningitis also shows low glucose and is not consistent with the normal glucose levels observed in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/screenshot-2024-09-10-161535.png\" alt=\"\" width=\"1000\" height=\"550\"></p>",
      "correct_choice_id": 46793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13041,
      "choices": [
        {
          "id": 52126,
          "text": "<p><span style=\"font-size:12.0pt;\">Wearing clothes of opposite sex</span></p>"
        },
        {
          "id": 52127,
          "text": "<p><span style=\"font-size:12.0pt;\">Public display of genitalia</span></p>"
        },
        {
          "id": 52128,
          "text": "<p><span style=\"font-size:12.0pt;\">Seeing a male undressing</span></p>"
        },
        {
          "id": 52129,
          "text": "<p><span style=\"font-size:12.0pt;\">Seeing a female undressing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Eonism can be defined as?&nbsp;</span>(INICET NOVEMBER 2022)</p>",
      "unique_key": "Q6931162",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379231,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A. Wearing clothes of opposite sex</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:12.0pt;\">Eonism /Transvestism involves wearing clothes of the opposite sex to derive pleasure.</span></li><li><span style=\"font-size:12.0pt;\">Eonism is named for Charles Eon de Beaumont, a French political adventurer who died in 1810 after posing as a woman for many years.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.<strong> Public display of genitalia</strong>  Exhibitionism, where an individual derives pleasure from exposing their genitals to others in public.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Seeing a male undressing:&nbsp;</strong>This can be a form of voyeurism, though it is not specifically defined as such. Voyeurism typically involves deriving pleasure from secretly observing others who are undressing or engaging in sexual activities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Seeing a female undressing</strong>- Voyeurism, where an individual derives pleasure from observing females undressing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eonism or transvestism is the act of wearing clothes of the opposite sex for pleasure, named after Charles Eon de Beaumont.</span></p>",
      "correct_choice_id": 52126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10429,
      "choices": [
        {
          "id": 41682,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leukemia</span></span></span></p>"
        },
        {
          "id": 41683,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lung cancer</span></span></span></p>"
        },
        {
          "id": 41684,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bladder cancer</span></span></span></p>"
        },
        {
          "id": 41685,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Skin cancer</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with occupational exposure to benzene presents with repeated infections, easy fatigability, weight loss, and evening rise of temperature. This occupational exposure will predispose him to which of the following cancers? (NEET PG 2021)</span></span></p>",
      "unique_key": "Q4915900",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379322,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Leukemia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Benzene exposure at work increases the risk of developing leukemia. The clinical history of repeated infections, easy fatigability, weight loss, and evening temperature rise with benzene exposure points to<strong> leukemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatic CYP2E1 converts benzene to an epoxide</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. The epoxide and other metabolites disrupt bone marrow progenitor cell differentiation, resulting in marrow aplasia and acute myeloid leukemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin lymphoma have all been linked to benzene exposure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Lung Cancer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Exposure to <strong>arsenic and its compounds, asbestos, beryllium</strong> and its compounds, chromium compounds, nickel compounds, radon, and its decay products can cause lung cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Bladder Cancer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Exposure to aryl amines, particularly <strong>2-naphthylamine</strong> and related compounds, <strong>cyclophosphamide,</strong> cigarette smoking, irradiation can cause bladder cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Skin Cancer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Exposure to <strong>UV rays, arsenic</strong>, and its compounds can cause skin cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Occupational exposure to benzene predisposes individuals to leukemia, as benzene metabolites disrupt bone marrow progenitor cell differentiation, leading to marrow aplasia and various types of leukemia. The clinical presentation of repeated infections, easy fatigability, weight loss, and evening rise of temperature in a patient with benzene exposure is highly suggestive of leukemia.</span></span></span></p>",
      "correct_choice_id": 41682,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10317,
      "choices": [
        {
          "id": 41234,
          "text": "<p><span style=\"font-size:12.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
        },
        {
          "id": 41235,
          "text": "<p><span style=\"font-size:12.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        },
        {
          "id": 41236,
          "text": "<p><span style=\"font-size:12.0pt;\">1-C, 2-B, 3-A, 4-D</span></p>"
        },
        {
          "id": 41237,
          "text": "<p><span style=\"font-size:12.0pt;\">1-D, 2-C, 3-B, 4-A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following developmental milestones: </span><span style=\"font-size:10.5pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-163743.png\" alt=\"\" width=\"700\" height=\"195\"></span></p>",
      "unique_key": "Q6758735",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379323,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1-B, 2-A, 3-D, 4-C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The developmental milestones are correctly matched as given in option B -1-b, 2-a, 3-d, 4-c.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Transfers objects - 6 to 7 months</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Social smile - 1 to 2 months</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pincer grasp - 9 to 12 months</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Walks 1-2 steps - 12 to 15 months</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Memorize the typical age ranges for key developmental milestones in infants, such as transferring objects, social smiling, pincer grasp, and walking.</span></p>",
      "correct_choice_id": 41235,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10403,
      "choices": [
        {
          "id": 41578,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetralogy of Fallot</span></p>"
        },
        {
          "id": 41579,
          "text": "<p><span style=\"font-size:12.0pt;\">Total anomalous pulmonary venous circulation</span></p>"
        },
        {
          "id": 41580,
          "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid atresia</span></p>"
        },
        {
          "id": 41581,
          "text": "<p><span style=\"font-size:12.0pt;\">Transposition of great arteries</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following congenital heart disease has equal saturation in all the chambers of the heart? (INICET NOV 2021)</span></p>",
      "unique_key": "Q8875403",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379324,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Total anomalous pulmonary venous circulation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">TAPVC is a congenital heart defect where oxygenated blood from the pulmonary veins does not reach the left atrium but instead reaches the right atrium, which contains deoxygenated blood.</span></li><li><span style=\"font-size:12.0pt;\">The pulmonary veins drain into the superior vena cava or the inferior vena cava, or both, causing a total mixing lesion. This mixing lesion leads to the oxygenated blood passing to the right ventricle and pulmonary artery, and to the left atrium through the atrial septal defect or the patent foramen ovale, and then to the left ventricle.</span></li><li><span style=\"font-size:12.0pt;\">The left atrium receives blood only from this shunt and not from the pulmonary veins, as all of them are draining to the right atrium.</span></li><li><span style=\"font-size:12.0pt;\">This shunt causes equal saturation of oxygenated blood in all four chambers of the heart since the blood from the right atrium reaches all other chambers.&nbsp; TAPVC can present with cyanosis, respiratory distress, tachypnea, tachycardia, and poor feeding in neonates.</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis is confirmed by echocardiography, which shows the abnormal venous return of the pulmonary veins.</span></li><li><span style=\"font-size:12.0pt;\">Treatment requires surgical repair to establish normal pulmonary venous return and improve oxygen saturation. The surgery should be performed as soon as possible to prevent irreversible pulmonary hypertension and cardiac failure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/112.jpg\" alt=\"\" width=\"300\" height=\"308\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tetralogy of Fallot</strong>: Tetralogy of fallot will not have some saturation in all chambers. Remember the x ray finding is  boot shape heart </span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tricuspid atresia</strong>: Tricuspid atresia will have decrease blood flow going from right atrium to right ventricle. So there will be difference in saturation in chambers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Transposition of great arteries</strong>: In this condition the pulmonary artery is attached to the left ventricle &amp; aorta is attached to the right ventricle which leads to parallel circulation. There will be saturation difference.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Total Anomalous Pulmonary Venous Circulation (TAPVC), there is equal oxygen saturation in all chambers of the heart due to the complete mixing of oxygenated and deoxygenated blood in the right atrium.</span></p>",
      "correct_choice_id": 41579,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5875,
      "choices": [
        {
          "id": 23470,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hot flashes</span></span></span></p>"
        },
        {
          "id": 23471,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CAD Prophylaxis</span></span></span></p>"
        },
        {
          "id": 23472,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osteoporosis</span></span></span></p>"
        },
        {
          "id": 23473,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature menopause</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy is not indicated for:&nbsp;</span></span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q3545924",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379325,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) CAD Prophylaxis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) is not recommended for the prophylaxis of coronary artery disease (CAD). Although there was some belief in the past that HRT might provide cardiovascular benefits, extensive research has shown that HRT does not prevent CAD and may, in fact, increase the risk of certain cardiovascular events in some women.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HRT is primarily indicated for the management of symptoms associated with menopause and for certain therapeutic and prophylactic uses:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapeutic Indications:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gonadal dysgenesis in adolescents</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature ovarian failure</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hot flashes (vasomotor symptoms)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginal dryness</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prophylactic Indications:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prevention of osteoporosis in postmenopausal women</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risks of HRT:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of endometrial cancer (particularly with unopposed estrogen in women with an intact uterus)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of breast cancer</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of ovarian cancer</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of thromboembolism</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Possible adverse effects on lipid profiles</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of gallstones and liver dysfunction</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hot flashes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> HRT is widely used to manage hot flashes and other vasomotor symptoms associated with menopause. It is one of the most effective treatments for these symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Osteoporosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> HRT is used prophylactically to prevent osteoporosis in postmenopausal women by maintaining bone density and reducing the risk of fractures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Premature menopause:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Women experiencing premature menopause or premature ovarian failure can benefit from HRT to manage symptoms and reduce the long-term risks associated with early loss of estrogen, including osteoporosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) is not indicated for the prophylaxis of coronary artery disease (CAD).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology 6<sup>th</sup> edition pg 61,62</span></strong></span></span></p>",
      "correct_choice_id": 23471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11162,
      "choices": [
        {
          "id": 44614,
          "text": "<p><span style=\"font-size:18px;\">Yellow</span></p>"
        },
        {
          "id": 44615,
          "text": "<p><span style=\"font-size:18px;\">Red</span></p>"
        },
        {
          "id": 44616,
          "text": "<p><span style=\"font-size:18px;\">Blue</span></p>"
        },
        {
          "id": 44617,
          "text": "<p><span style=\"font-size:18px;\">Transparent</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A nurse removes her latex gloves contaminated with blood and bodily fluids after a procedure. According to biomedical waste management guidelines, into which colored bag should she place the used gloves for disposal? </strong><i><strong>[INICET NOV 2020]</strong></i></span></p>",
      "unique_key": "Q2152016",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379326,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Red</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Latex gloves contaminated with blood and other bodily fluids are considered contaminated waste (recyclable) and should be disposed of in red-colored bags or containers.</span></li><li><span style=\"font-size:18px;\">This category includes items like tubing, bottles, intravenous tubes and sets, catheters, urine bags, syringes (without needles), and gloves.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-092807_eQEsiJX.png\" alt=\"\" width=\"1000\" height=\"824\"></span></p>",
      "correct_choice_id": 44615,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13100,
      "choices": [
        {
          "id": 52362,
          "text": "<p><span style=\"font-size:12.0pt;\">Pinguecula</span></p>"
        },
        {
          "id": 52363,
          "text": "<p><span style=\"font-size:12.0pt;\">Pterygium</span></p>"
        },
        {
          "id": 52364,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemical burn</span></p>"
        },
        {
          "id": 52365,
          "text": "<p><span style=\"font-size:12.0pt;\">Thermal burn</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the diagnosis of the condition seen in the image? (</span>AIIMS Nov 2017)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture8_4OudRq9.jpg\" alt=\"\" width=\"300\" height=\"266\"></span></p>",
      "unique_key": "Q7784689",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379327,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pterygium</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given image shows Pterygium which is a triangular/wing shaped encroachment of conjunctiva on the cornea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>PTERYGIUM:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A pterygium is a triangular fibrovascular subepithelial ingrowth of degenerative bulbar conjunctival tissue over the limbus onto the cornea.</span></li><li><span style=\"font-size:12.0pt;\">Typically develops in patients who have been living in sunny countries and may represent a response to UV exposure and chronic surface dryness.</span></li><li><span style=\"font-size:12.0pt;\">Familial.</span></li><li><span style=\"font-size:12.0pt;\">Histologically similar to a pinguecula: shows elastotic degenerative changes in vascularized subepithelial stromal collagen.</span></li><li><span style=\"font-size:12.0pt;\">Encroaches onto the cornea, invading the Bowman layer.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical features&nbsp;</strong></span><ul><li><span style=\"font-size:12.0pt;\">Mostly <strong>asymptomatic</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Irritation</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>and</strong>&nbsp;<strong>grittiness&nbsp;</strong>are caused by a dellen  localized drying effect.</span></li><li><span style=\"font-size:12.0pt;\">Lesions may interfere with vision by obscuring the visual axis or inducing <strong>astigmatism</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cosmesis</strong> may be a significant problem.</span></li><li><span style=\"font-size:12.0pt;\">Extensive lesions (if recurrent) may have <strong>subconjunctival</strong> <strong>fibrosis</strong> extending to the fornices causing restricted ocular excursion.</span></li><li><span style=\"font-size:12.0pt;\">Made up of <strong>three</strong> <strong>parts</strong>: a cap (an avascular halo-like zone at the advancing edge), a head and a body.</span></li><li><span style=\"font-size:12.0pt;\">Linear epithelial iron deposition <strong>(Stocker line): </strong>seen in the corneal epithelium anterior to the head of the pterygium.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fuchs islets</strong> are small discrete whitish flecks consisting of clusters of pterygial epithelial cells often present at the advancing edge.</span></li><li><span style=\"font-size:12.0pt;\">Aggressive growth or an atypical appearance should prompt excision biopsy.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pinguecula:</strong> Unlike pterygium, a pinguecula does not grow across the cornea but remains confined to the conjunctiva. It appears as a yellowish, slightly raised lesion on the conjunctiva near the cornea, usually on the nasal side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chemical Burn:</strong> This would typically present with more diffuse redness, possible corneal haze, and severe discomfort. The eye would look more acutely inflamed and could show signs of limbal ischemia or whitening.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Thermal Burn:</strong> Similar to chemical burns, a thermal burn would involve more diffuse damage and typically present signs of acute injury, such as eyelid burns, charred lashes, or more extensive tissue damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pterygium is identifiable by its characteristic growth from the conjunctiva onto the cornea, often due to prolonged UV exposure, appearing as a wing-shaped film on the eye.</span></p>",
      "correct_choice_id": 52363,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31889,
      "choices": [
        {
          "id": 127426,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti TPO antibody</span></p>"
        },
        {
          "id": 127427,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti thyroglobulin antibody</span></p>"
        },
        {
          "id": 127428,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti Thyroid stimulating antibody</span></p>"
        },
        {
          "id": 127429,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti thyroid receptor antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A middle aged male presented with features of neck swelling, exophthalmos, sweating, tachycardia and tremors. Which of the following is the likely associated finding in this patient? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-193206.jpg\" alt=\"\" width=\"250\" height=\"398\"></span></p>",
      "unique_key": "Q2728834",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379328,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Anti thyroid receptor antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient presents with classic signs of hyperthyroidism, including:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Neck swelling  Goiter</span></li><li><span style=\"font-size:12.0pt;\">Exophthalmos  Bulging eyes</span></li><li><span style=\"font-size:12.0pt;\">Sweating, tachycardia, tremors  Signs of increased sympathetic activity</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given history and the picture of the patient suggest a diagnosis of hyperthyroidism the commonest cause of which is <strong>Gravess disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common antibody subtype, known as thyroid-stimulating immunoglobulin (TSI), is observed in approximately 90% of patients. TSI binds to the TSH receptor and mimics its actions, stimulating adenyl cyclase and increasing the release of thyroid hormones.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti thyroid stimulating antibody cannot be the answer as such an antibody</span></li><li><span style=\"font-size:12.0pt;\">Since TSI stimulates the gland for the formation of thyroid hormones.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-193354.jpg\" alt=\"\" width=\"1000\" height=\"278\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anti-TPO antibody:</strong> Associated with Hashimoto's thyroiditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-thyroglobulin antibody:</strong> Also associated with Hashimoto's thyroiditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anti-thyroid stimulating antibody:</strong> Incorrect terminology for TSI, which is already covered under anti-thyroid receptor antibody.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Graves' disease is associated with anti-thyroid receptor antibodies (TSI), which stimulate the thyroid gland to produce excess thyroid hormones, leading to hyperthyroidism. The presence of neck swelling, exophthalmos, and other hyperthyroid symptoms strongly suggests this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Graves Disease  Key Features:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KgbS7tT.png\" width=\"1030\" height=\"419\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins 10<sup>th</sup>/ 1081</strong></span></p>",
      "correct_choice_id": 127429,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44031,
      "choices": [
        {
          "id": 175783,
          "text": "<p><span style=\"font-size:12pt;\">Integrin</span></p>"
        },
        {
          "id": 175784,
          "text": "<p><span style=\"font-size:12pt;\">Cadherin</span></p>"
        },
        {
          "id": 175785,
          "text": "<p><span style=\"font-size:12pt;\">Occludens</span></p>"
        },
        {
          "id": 175786,
          "text": "<p><span style=\"font-size:12pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which extracellular cell adhesion is disrupted by Vibrio cholerae? (INICET NOV 2023)</span></p>",
      "unique_key": "Q6616611",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379329,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Occludens</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vibrio cholerae disrupts occludens, specifically targeting tight junctions between intestinal epithelial cells, which impairs their barrier function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Integrin</strong>: Primarily involved in cell-extracellular matrix adhesion, not typically disrupted by Vibrio cholerae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Cadherin</strong>: Important for cell-cell adhesion in adherens junctions, not the main target of Vibrio cholerae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. None of the above</strong>: Incorrect, as occludens are indeed affected by Vibrio cholerae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vibrio cholerae specifically targets occludens, which are crucial components of tight junctions, thereby compromising intestinal epithelial barrier functions.</span></p>",
      "correct_choice_id": 175785,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57191,
      "choices": [
        {
          "id": 228153,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Allergic rhinitis</span></span></span></p>"
        },
        {
          "id": 228154,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Cystic fibrosis</span></span></span></p>"
        },
        {
          "id": 228155,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Intrinsic (non-allergic) asthma</span></span></span></p>"
        },
        {
          "id": 228156,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wegener&#39;s granulomatosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 45-year-old woman with a history of chronic sinusitis presents to the clinic with complaints of nasal congestion, anosmia (loss of smell), and recurrent episodes of facial pressure. She reports that these symptoms have been persistent for the past several months, despite using over-the-counter nasal sprays and decongestants. On physical examination, nasal endoscopy reveals bilateral pale, edematous masses in the nasal cavity consistent with nasal polyps. She denies any history of allergies or asthma as a child but notes that she developed wheezing and shortness of breath in her late 30s, which has been managed with inhalers. Nasal polyps are commonly associated with which conditions?</span></span></span></p>",
      "unique_key": "Q9910467",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379330,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Intrinsic (non-allergic) asthma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Intrinsic asthma, also known as non-allergic asthma, is commonly associated with nasal polyps. This form of asthma typically develops in adulthood and is not linked to an atopic or allergic component. The pathophysiology involves a non-IgE-mediated mechanism with chronic inflammation driven by eosinophils and neutrophils. Nasal polyps in intrinsic asthma arise from persistent inflammation of the nasal passages and sinuses, contributing to the common symptoms of nasal obstruction and anosmia. This condition contrasts with allergic asthma, which usually involves IgE-mediated hypersensitivity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Allergic rhinitis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> While allergic rhinitis is a common cause of nasal symptoms, it is more frequently associated with allergic asthma rather than intrinsic asthma. Nasal polyps can occur but are less characteristic in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Cystic fibrosis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Nasal polyps are seen in patients with cystic fibrosis due to chronic sinus infections and inflammation. However, cystic fibrosis is a genetic disorder and not typically linked to adult-onset asthma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Wegener&#39;s granulomatosis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Also known as granulomatosis with polyangiitis, this condition can cause nasal symptoms, but it is characterized by necrotizing vasculitis, granuloma formation, and is not commonly associated with nasal polyps.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Nasal polyps are commonly associated with intrinsic (non-allergic) asthma, chronic sinusitis, and conditions involving persistent airway inflammation, such as cystic fibrosis. Unlike allergic asthma, intrinsic asthma does not involve IgE-mediated pathways and often develops in adulthood, with nasal polyps being a frequent comorbidity due to chronic inflammation of the nasal passages. Understanding the associations between nasal polyps and respiratory conditions helps guide diagnosis and management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/14/picture4.jpg\" style=\"height:354px; width:800px\" /></span></span></span></p>",
      "correct_choice_id": 228155,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9846,
      "choices": [
        {
          "id": 39350,
          "text": "<p><span style=\"font-size:12.0pt;\">Spectrin defect is commonly observed</span></p>"
        },
        {
          "id": 39351,
          "text": "<p><span style=\"font-size:12.0pt;\">Spherical cells may be seen</span></p>"
        },
        {
          "id": 39352,
          "text": "<p><span style=\"font-size:12.0pt;\">Cells don't lyse in hypotonic solution</span></p>"
        },
        {
          "id": 39353,
          "text": "<p><span style=\"font-size:12.0pt;\">Cells lyse in hypertonic solution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true regarding glucose-6-phosphate dehydrogenase deficiency?</span> <span style=\"font-size:12.0pt;\">(AIIMS MAY 2020)</span></p>",
      "unique_key": "Q7436492",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379381,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Spherical cells may be seen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">G6PD deficiency can have spherical red cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glucose-6-phosphate dehydrogenase (G6PD. is an enzyme that helps in the synthesis of NADPH. NADPH helps in keeping glutathione in a reduced state (GSH). This reduced glutathione acts as a defense against oxidative damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In G6PD deficiency, RBCs are exposed to oxidants. These cross-linking of the reactive sulfhydryl groups in the globin chain of hemoglobin. These are then deposited as inclusions in RBC membranes as Heinz bodies. <strong>When these RBCs pass-through spleen, macrophages pluck out these membrane inclusions. The remaining cells are seen as bite cells. Less severely damaged cells lose a part of their membrane, forming spherocytes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/978.jpg\" alt=\"\" width=\"488\" height=\"342\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Spectrin</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Spectrin is a part of the RBC membrane skeleton. It is commonly defective in hereditary spherocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Cells don't lyse in hypotonic solution</strong>: Normal biconcave RBCs have a bit of an 'extra space'. They can accommodate a little fluid when exposed to a hypotonic solution. But spherocytes have already lost a part of its membrane, so are relatively full. Hence if they are placed in a hypotonic solution, they absorb more fluid and result in lysis of RBCs. This forms the basis of testing spherocytes in Hereditary spherocytosis or G6PD and is known as <strong>osmotic fragility testing.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Cells lyse in hypertonic solution</strong>: Placing RBCs in a hypertonic solution causes them to lose water and shrink, but significant hemolysis does not typically occur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What is G6PD Deficiency?</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">A genetic enzymopathy, inherited in an X-linked recessive manner.</span></li><li><span style=\"font-size:12.0pt;\">G6PD is an enzyme in the pentose phosphate pathway that generates NADPH, which helps maintain reduced glutathione (GSH).</span></li><li><span style=\"font-size:12.0pt;\">GSH protects red blood cells (RBCs) from oxidative damage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What Happens in G6PD Deficiency?</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Without enough G6PD, RBCs are vulnerable to oxidative stress, such as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Infections</span></li><li><span style=\"font-size:12.0pt;\">Drugs (e.g., sulfa drugs, antimalarials)</span></li><li><span style=\"font-size:12.0pt;\">Fava beans</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key peripheral smear findings:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Bite cells</span></li><li><span style=\"font-size:12.0pt;\">Heinz bodies</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In glucose-6-phosphate dehydrogenase (G6PD) deficiency, red blood cells become spherical (spherocytes) due to oxidative damage and the removal of damaged membrane by the spleen, leading to hemolytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref:&nbsp;Robbins and Cotrans pathologic basis of disease 8<sup>th</sup> edition pg 1198-1199</strong></span></p>",
      "correct_choice_id": 39351,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6776,
      "choices": [
        {
          "id": 27073,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A, B, C, D</span></span></span></p>"
        },
        {
          "id": 27074,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">A, D</span></span></span></p>"
        },
        {
          "id": 27075,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">B, D</span></span></span></p>"
        },
        {
          "id": 27076,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">A, C, D</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following can be used to calculate the cardiac output?&nbsp;</span></span>(INICET MAY 2022)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ECHO.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ventilation-perfusion scan.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thermodilution.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fick&#39;s principle</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>",
      "unique_key": "Q9433905",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379382,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. D) A, C, D</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fick principle, thermodilution, and ECHO can be used to measure cardiac output.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cardiac output is the amount of blood pumped by the heart into the aorta every minute. The average cardiac output is 5L/min and can be measured by various indirect methods.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Doppler echocardiography</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a method for detecting the direction and velocity of moving blood within the heart. This is also a popular method to measure cardiac output. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Thermodilution method</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - a known volume of cold sterile solution is injected into the right atrium via inferior vena cava by using a catheter. Cardiac output is measured by determining the resultant change in the blood temperature in pulmonary artery. For this purpose, two thermistors (temperature transducers) are used. One of them is placed in the inferior vena cava and the second one is placed in pulmonary artery. A pulmonary artery catheter is used to place the thermistors in their positions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. The Fick principle</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">, as applied to cardiac output, relies on the recognition that the total uptake of oxygen by the peripheral tissues is equal to the product of the blood flow to the peripheral tissues and the arterial-venous oxygen concentration difference.</span></span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formula:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-120204.png\" style=\"height:137px; width:1000px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Indirect methods used to measure cardiac output:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">By using Fick principle</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Indicator (dye) dilution technique</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thermodilution technique</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ultrasonic Doppler transducer technique</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Doppler echocardiography</span></span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ballisto cardiography.</span></span></li>\r\n</ol>",
      "correct_choice_id": 27076,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10444,
      "choices": [
        {
          "id": 41742,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyanocobalamin deficiency</span></p>"
        },
        {
          "id": 41743,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid deficiency</span></p>"
        },
        {
          "id": 41744,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency</span></p>"
        },
        {
          "id": 41745,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary spherocytosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A software engineer presents to the outpatient department with easy fatigability. He gives a history of sitting in front of the computer for 12 - 14 hours. He consumes a lot of junk food with very less fruits and vegetables. Hb is 9gm/dl and MCV 120 fl. What is the most likely cause of this patient's anemia? (NEET PG 2021)</span></p>",
      "unique_key": "Q6766913",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379383,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Folic acid deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given laboratory values showing anemia and increased MC are suggestive of megaloblastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This could be due to a lack of cyanocobalamin or folic acid. The lack of fruits and vegetables in the past suggests folic acid deficiency. (folic acid word derived from foliage-green leafy vegetables)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Animal products such as meat, fish, milk, and eggs are good sources of vitamin B12.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Green vegetables like lettuce, spinach, asparagus, and broccoli are high in folic acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In megaloblastic anemia, peripheral blood examination reveals oval macrocytes with anisocytosis and poikilocytosis. MCV is typically greater than 100 fL. (normal value: 80-100 fL). The MCHC is not elevated because most macrocytes lack the central pallor of normal red cells and appear hyperchromic. The number of reticulocytes is low. Neutrophils are larger than normal and have five or more nuclear lobules, indicating nuclear hyper segmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cyanocobalamin deficiency:&nbsp;</strong>Although vitamin B12 deficiency also causes megaloblastic anemia, the dietary history here suggests folic acid deficiency as the primary cause, given the lack of fruits and vegetables.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Iron deficiency:&nbsp;</strong>Iron deficiency anemia typically presents with microcytic (low MCV), hypochromic anemia, not macrocytic anemia as indicated by the elevated MCV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hereditary spherocytosis:&nbsp;</strong>This is a hemolytic anemia characterized by the presence of spherocytes (spherical red blood cells) and usually presents with a normal or slightly decreased MCV, not the significantly elevated MCV seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most likely cause of anemia in this patient, given the elevated MCV and dietary habits lacking in fruits and vegetables, is folic acid deficiency. Megaloblastic anemia due to folic acid deficiency presents with macrocytic red blood cells and can be confirmed by dietary history and characteristic blood smear findings.</span></p>",
      "correct_choice_id": 41743,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14422,
      "choices": [
        {
          "id": 57649,
          "text": "<p><span style=\"font-size:12.0pt;\">Upper GI endoscopy</span></p>"
        },
        {
          "id": 57650,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol breath test</span></p>"
        },
        {
          "id": 57651,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum lipase</span></p>"
        },
        {
          "id": 57652,
          "text": "<p><span style=\"font-size:12.0pt;\">CECT</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old male with a history of heavy alcohol use presents to the emergency department with severe epigastric pain that radiates to the back and recurrent vomiting. On examination, the patient has tenderness and guarding in the upper epigastrium. The chest x-ray is normal. What is the next step in the management of this patient? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q9163011",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379384,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Serum Lipase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Serum lipase is an enzyme produced by the pancreas. Elevated levels of serum lipase are a hallmark of acute pancreatitis. It is a critical diagnostic test to confirm the diagnosis in a patient with symptoms suggestive of pancreatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Upper GI endoscopy</strong>: Upper GI endoscopy is used to visualize the upper gastrointestinal tract, which may help diagnose conditions like peptic ulcers or esophagitis. However, in this case, the symptoms and clinical findings are more indicative of acute pancreatitis rather than upper GI issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B.</strong> <strong>Alcohol breath</strong> <strong>test</strong>: An alcohol breath test is used to detect recent alcohol consumption. While the patient has a history of heavy alcohol use, this test won't provide information about the current medical condition, such as pancreatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CECT (Contrast-enhanced computed tomography)</strong>: A contrast-enhanced CT scan (CECT) can be a valuable tool for confirming the diagnosis of acute pancreatitis and assessing its severity. However, in many cases, a serum lipase test is ordered first because it's a quicker and less invasive way to diagnose acute pancreatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Abdominal pain with recurrent vomiting in a chronic alcoholic with upper epigastric guarding is highly suggestive of pancreatitis.</span></li><li><span style=\"font-size:12.0pt;\">A normal erect chest x-ray suggests that there is no pneumoperitoneum, effectively ruling out perforation.</span></li><li><span style=\"font-size:12.0pt;\">In this setting, the main differential diagnosis to consider is pancreatitis.</span></li><li><span style=\"font-size:12.0pt;\">The next appropriate investigation would be a serum lipase test to confirm the diagnosis of pancreatitis.</span></li></ul>",
      "correct_choice_id": 57651,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14086,
      "choices": [
        {
          "id": 56305,
          "text": "<p><span style=\"font-size:12.0pt;\">C1</span></p>"
        },
        {
          "id": 56306,
          "text": "<p><span style=\"font-size:12.0pt;\">C2</span></p>"
        },
        {
          "id": 56307,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 56308,
          "text": "<p><span style=\"font-size:12.0pt;\">C4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old chef presented with complaints of leg pain and swelling. Upon examination, he was diagnosed with varicose veins. Further examination revealed the presence of skin eczema and lipodermatosclerosis. According to the CEAP classification system, He would be classified as: (AIIMS NOV 2020)</span></p>",
      "unique_key": "Q6193998",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379385,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) C4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation of the CEAP Classification:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The CEAP classification is a system used to categorize venous disease based on clinical, etiologic, anatomic, and pathophysiologic criteria. Here's a breakdown:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>C</strong>: Clinical classification</span></li><li><span style=\"font-size:12.0pt;\"><strong>E</strong>: Etiologic classification</span></li><li><span style=\"font-size:12.0pt;\"><strong>A</strong>: Anatomic classification</span></li><li><span style=\"font-size:12.0pt;\"><strong>P</strong>: Pathophysiologic classification</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"C\" or clinical classification is divided as follows:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>C0</strong>: No visible or palpable signs of venous disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>C1</strong>: Telangiectasias or reticular veins.</span></li><li><span style=\"font-size:12.0pt;\"><strong>C2</strong>: Varicose veins.</span></li><li><span style=\"font-size:12.0pt;\"><strong>C3</strong>: Edema.</span></li><li><span style=\"font-size:12.0pt;\"><strong>C4</strong>: Skin changes without ulceration. This is further divided into:</span><ul><li><span style=\"font-size:12.0pt;\"><strong>C4a</strong>: Pigmentation or eczema.</span></li><li><span style=\"font-size:12.0pt;\"><strong>C4b</strong>: Lipodermatosclerosis or atrophie blanche.</span></li><li><span style=\"font-size:12.0pt;\"><strong>C4c</strong>: Corona phlebectatica</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>C5</strong>: Skin changes with healed ulceration.</span></li><li><span style=\"font-size:12.0pt;\"><strong>C6</strong>: Skin changes with active ulceration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In summary, the patient's symptoms of varicose veins combined with skin changes such as eczema and lipodermatosclerosis correspond to the C4 classification in the CEAP system.</span></p>",
      "correct_choice_id": 56308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16136,
      "choices": [
        {
          "id": 64504,
          "text": "<p><span style=\"font-size:12pt;\">Neurofibromatosis</span></p>"
        },
        {
          "id": 64505,
          "text": "<p><span style=\"font-size:12pt;\">Liposarcoma</span></p>"
        },
        {
          "id": 64506,
          "text": "<p><span style=\"font-size:12pt;\">Cirsoid Aneurysm</span></p>"
        },
        {
          "id": 64507,
          "text": "<p><span style=\"font-size:12pt;\">Varicocele</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A woman in her early 40s comes to your clinic, displaying a winding, pronounced swelling that covers the left region of her scalp and face, as visible in the provided image. Upon physical examination, you notice the swelling exhibits a rhythmic pulsation. When listening to the area with a stethoscope, a sound indicative of turbulent blood flow - a bruit - is heard. What could be the most probable diagnosis in this case? (NEET PG 2020)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-153927.jpg\" alt=\"\" width=\"350\" height=\"350\"></p>",
      "unique_key": "Q7038118",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379386,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Cirsoid Aneurysm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The above image is suggestive of a Cirsoid aneurysm.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Definition:&nbsp;</strong>Cirsoid aneurysms, also known as <strong>arteriovenous fistulas or arteriovenous malformations, </strong>are abnormal connections between arteries and veins without the usual intervening capillaries.</span></li><li><span style=\"font-size:12pt;\"><strong>Common locations:&nbsp;</strong>They most commonly occur in the scalp and face, although they can occur in other locations in the body.</span></li><li><span style=\"font-size:12pt;\"><strong>Causes:&nbsp;</strong>They can be congenital (present at birth) or acquired, often as a result of trauma.</span></li><li><span style=\"font-size:12pt;\"><strong>Symptoms:&nbsp;</strong>Cirsoid aneurysms often present as a pulsatile mass, sometimes accompanied by a bruit (a sound heard over an artery due to turbulent blood flow). They can cause cosmetic concerns, headaches, and in severe cases, bleeding.</span></li><li><span style=\"font-size:12pt;\"><strong>Diagnosis:&nbsp;</strong>They can be diagnosed through physical examination and imaging studies such as ultrasound, CT, or MRI. Angiography can provide a detailed view of the blood vessels.</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment:&nbsp;</strong>Treatment options include surgical excision, embolization (blocking off the abnormal vessels), or a combination of both. The choice of treatment depends on the size and location of the aneurysm, and the patient's overall health status.</span></li><li><span style=\"font-size:12pt;\"><strong>Complications:&nbsp;</strong>If left untreated, they can result in complications such as bleeding, ulceration, and, rarely, heart failure due to the increased blood flow through the malformation.</span></li></ol><p><span style=\"font-size:12pt;\">&nbsp;</span></p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Neurofibromatosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\"><strong>Location:&nbsp;</strong>Neurofibromatosis (NF) is a genetic disorder that can affect multiple systems, including the skin and nerves.</span></li><li><span style=\"font-size:12pt;\"><strong>Symptoms:&nbsp;</strong>Symptoms vary but can include skin tumors (neurofibromas), caf-au-lait spots, and neurological problems</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-154036.jpg\" alt=\"\" width=\"450\" height=\"674\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Liposarcoma:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Location:</strong> Liposarcoma is a type of soft tissue sarcoma that typically arises in fat cells in various parts of the body, including the limbs and abdomen.</span></li><li><span style=\"font-size:12pt;\"><strong>Causes:&nbsp;</strong>The exact cause is often unknown, but some genetic factors may contribute. <strong>Symptoms:</strong> Symptoms may include a painless lump, swelling, or pain in the affected area.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Varicocele:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Location:&nbsp;</strong>Varicoceles are dilated veins in the scrotum, specifically in the spermatic cord. <strong>Causes:</strong> Varicoceles often develop due to faulty valves in the testicular veins, which allow blood to pool in the scrotum.</span></li><li><span style=\"font-size:12pt;\"><strong>Symptoms:</strong> They may cause a dull ache or discomfort in the scrotum, especially after prolonged standing.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-154125.jpg\" alt=\"\" width=\"450\" height=\"690\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cirsoid aneurysms are arteriovenous malformations commonly found in the scalp and face, presenting as pulsatile masses with associated bruits. Proper diagnosis and treatment are essential to prevent complications such as bleeding and cosmetic concerns.</span></p>",
      "correct_choice_id": 64506,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24407,
      "choices": [
        {
          "id": 97589,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrin - G cells, Antrum</span></p>"
        },
        {
          "id": 97590,
          "text": "<p><span style=\"font-size:12.0pt;\">Secretin - S cells, Duodenum</span></p>"
        },
        {
          "id": 97591,
          "text": "<p><span style=\"font-size:12.0pt;\">CCK - I cells, Duodenum and jejunum</span></p>"
        },
        {
          "id": 97592,
          "text": "<p><span style=\"font-size:12.0pt;\">Motilin - M cells, Duodenum and Jejunum</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the subsequent pairs are inaccurately matched? (</span>INICET May 2023)</p>",
      "unique_key": "Q1067531",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379527,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><strong>Ans. D) Motilin - M cells, Duodenum and Jejunum</strong></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Motilin is a gastrointestinal hormone produced by enterochromaffin cells and Mo cells (Not M cells) present in the stomach, small intestine, and colon.</span><br><br>M cells, or microfold cells, are specialized epithelial cells in the gut-associated lymphoid tissue (GALT) that play a crucial role in initiating mucosal immune responses, it does not release Motilin.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Gastrin - G cells, Antrum:</strong>&nbsp;Correct. Gastrin is produced by G cells located in the antrum of the stomach and stimulates H+ secretion by parietal cells.</p><p>&nbsp;</p><p><strong>Option B. Secretin - S cells, Duodenum:</strong>&nbsp;Correct. Secretin is produced by S cells in the duodenum and decreases gastric acid secretion while increasing pancreatic bicarbonate secretion.</p><p>&nbsp;</p><p><strong>Option C. CCK - I cells, Duodenum and jejunum:</strong>&nbsp;Correct. Cholecystokinin (CCK) is produced by I cells in the duodenum and jejunum, increasing pancreatic enzyme secretion and gallbladder contraction while decreasing gastric emptying and relaxing the sphincter of Oddi.</p><p>&nbsp;</p><p><strong>Option D. Motilin - M cells, Duodenum and Jejunum:</strong>&nbsp;Incorrect. Motilin is produced by enterochromaffin cells and Mo cells in the stomach, small intestine, and colon, not exclusively by M cells in the duodenum and jejunum.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><strong>GIT HORMONES</strong></p><p>&nbsp;</p><ul><li>Gastrin  G cell at antrum. Acts on Parietal cells stimulate the H+ K+ ATPase.</li><li>Secretin  S cells at Duodenum. Decrease gastric acid secretion and Increase pancreatic HCO3- secretion.</li><li>CCK-PZ  I cells in duodenum and jejunum. Increase pancreatic HCO3- secretion, Increase gall bladder contraction, Decrease gastric emptying and increase sphincter of Oddi relaxation.</li><li>GIP  K cells in duodenum and jejunum. Decrease H+ secretion and increase insulin release.</li><li>Motilin  Mo cells in small intestine. Produces migrating motor complexes (MMCs).</li></ul>",
      "correct_choice_id": 97592,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57192,
      "choices": [
        {
          "id": 228157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Myoglobin</span></span></span></p>"
        },
        {
          "id": 228158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Troponin I (Tropl)</span></span></span></p>"
        },
        {
          "id": 228159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Lactate Dehydrogenase (LDH)</span></span></span></p>"
        },
        {
          "id": 228160,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Troponin T (TropT)</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male with a history of hypertension and hyperlipidemia presents to the emergency department with severe chest pain radiating to his left arm, which started 3 hours ago. He appears diaphoretic and anxious. His blood pressure is 150/90 mm Hg, heart rate is 95 beats per minute, and ECG shows nonspecific ST-segment changes. Given the timing of his symptoms, which biomarker would be the most appropriate investigation to diagnose myocardial infarction (MI) within 2-4 hours of symptom onset?</span></span></p>",
      "unique_key": "Q2521591",
      "question_audio": null,
      "question_video": null,
      "map_id": 12379528,
      "difficulty_level": "difficult",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Myoglobin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Myoglobin is one of the earliest cardiac biomarkers to rise after myocardial injury, typically elevating within 1 to 4 hours of symptom onset. It peaks around 12 hours and normalizes within 24 hours. Due to its rapid rise, myoglobin is particularly useful in detecting myocardial infarction in the early hours when other biomarkers may still be within normal ranges. However, its lack of specificity to cardiac tissue means that while it is highly sensitive for early detection, it must be used in conjunction with other tests to confirm a diagnosis of MI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Troponin I (Tropl)</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Troponin I starts to rise within 3 to 12 hours after myocardial infarction, making it less suitable for diagnosing MI within 2-4 hours of onset. Although Troponin I is highly specific for cardiac injury, its elevation time frame does not align with the immediate early phase of MI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Lactate Dehydrogenase (LDH)</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">LDH is a less specific marker of tissue injury and usually begins to rise 10 to 12 hours after myocardial infarction, peaking at 48 to 72 hours. It is not used for early diagnosis of MI due to its delayed rise and lack of specificity for cardiac muscle damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Troponin T (TropT)</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Troponin T rises within 3 to 12 hours after myocardial infarction, peaking between 12 and 48 hours, and remains elevated for 7 to 10 days. It is highly specific for myocardial injury but is not an ideal early marker within the 2-4 hour window of symptom onset.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Myoglobin is the earliest cardiac biomarker to rise following myocardial injury, usually within 1 to 4 hours, making it particularly useful for diagnosing myocardial infarction in the acute phase. Troponins, while highly specific and sensitive for cardiac injury, typically begin to rise later, around 3 to 12 hours after symptom onset. Understanding the time courses of various biomarkers is crucial in selecting the appropriate tests for early diagnosis of myocardial infarction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/14/picture5_0KuCcDW.jpg\" style=\"height:216px; width:800px\" /></span></span></span></p>",
      "correct_choice_id": 228157,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}